integrate report year end december responsible management forest resource report print paper produce fsccertified source accordance standard forest stewardship council international certification body dedicate promote responsible forest stewardship control source nonvoc ink free mineral oilscorporate philosophy essence c n e n management provide value business otsukapeople create new product corporate culture otsukas goal development total healthcare company well health worldwide message president ryukangodo otsukas story keep corporate philosophy otsuka value ryukangodo sweat sweat recognize way otsukas strength recognize way jissho actualization sozosei creativity strive value creation model otsuka otsuka group support live people worldwide wide range process innovative creative product include pharmaceutical functional beverage functional discover core value creation process generate food dedicate cultivate dynamic corporate culture workplace reflect substance originality hard work vision healthcare company find way live harmony local community otsuka group approach sustainability practice natural environment contribute rich healthy life materiality material issue feature unique total healthcare company message cfo grow jissho advance unique actualization total healthcare company pharmaceutical business selfactualization nutraceutical business achievement completion achieve sustainability discovery truth health people quality environment measure covid otsukas goal governance corporate governance indispensable contributor sozosei director audit supervisory creativity board member people health worldwide discussion corporate governance pursue compliance otsuka capable otsuka group aim indispensable contributor people health worldwide fulfil deliver tax compliance risk management corporate philosophy aspect operation commitment improve people health worldwide unchanging value continue provide society operation esg content index encompass core business pharmaceutical business provide comprehensive health financial nonfinancial highlight support diagnosis treatment disease nutraceutical business help people main datum maintain improve daytoday health corporate information global network nutraceutical nutrition pharmaceutical group structure overview main operating company disclosure otsuka group stock information otsuka holdings co ltd integrate report provide value business total healthcare company otsuka group contribute people health worldwide create innovative product core business pharmaceutical business aim address unmet medical need nutraceutical business seek fulfill yettobeimagine need consumer provide value otsuka bring health people worldwide unmet medical need diagnosis treatment pharmaceutical business yettobeimagine need maintain improve daytoday health nutraceutical business otsuka holdings co ltd integrate report otsuka holdings co ltd integrate report otsukas goal development total healthcare company grow page otsuka group continuously develop total healthcare company provide product service lead resolution social issue aim bring health people worldwide present pursue otsuka base otsuka strength emphasis otsuka specify key material issue require focus prioritize effort goal indispensable contributor people health worldwide contribute realization sustainable society sustainable society pharmaceutical business social wellbeing provide value indispensable contributor bring health total healthcare page goal people health worldwide people worldwide physical mental wellbeing wellbee nutraceutical business page otsukas strength page achieve achieve sustainability page found present future cosmedic cosmetic medicine state health define constitution world health organizationwho ylesolc ot sessenisub gnipoleve seussi laicos sserdda ytilairetam pharma ceutical nutra chemical ceutical otc vvaalluuee ccrreeaattiioonn cosmedics mmooddeell ppaaggeess consumer clinical product nutrition medical diagnostic device otsuka holdings co ltd integrate report otsuka holdings co ltd integrate report message president q direction otsuka group head medium long term seek company continue contribute determined advance global market society purpose unique total healthcare company continuously advance company exist mediumterm management plan continuously create new concept product pursue creation unique value healthcare total healthcare marshal unique diverse business field range maintain improve dayto company contribute asset effectively connect true day health diagnosis treatment disease needs identify customer insight medium longterm basis envision sustainable society technology science pioneer society economy year year field overlap derive ahead aim indispensable contributor business niche field create people health worldwide provide innovative new value respond unmet yettobe products service otsuka group imagine health need produce leverage strength total healthcare base experience strength company q otsuka celebrate th anniversary september change change otsuka group decade tatsuo higuchi join otsuka revenue group carefully monitor flexibly adapt change president representative director ceo company billion yen usd million time consider large factor otsuka holdings co ltd exchange rate revenue fiscal continuous business operation year exceed billion yen usd billion foundation operating basis substantially increase japan hand basic mindset internationally managerial system evolve alter otsuka group inherit key people healthcare need considerably message leadership generation transform base factor decline unchanged corporate culture ryukangodo wish express empathy people afflict affected birthrate aging population lifestyle change sweat recognize way jissho actualization promote business capitalize strength sozosei creativity ryukangodo signifie process way covid include heartfelt gratitude healthcare confront weakness strength decay discover core substance professional support fall ill weakness complacent hard work practice jissho mean selfactualization hand weakness convert strength achievement completion discovery insight gain understanding address truth sozosei pursue otsuka world enter era change trend transform economy society otsuka group accept practice new capable delivering progress geopolitical risk advancement ai information communication thing create new value free stereotype easier say example sozosei conventional idea continuously advanced signifie create scratch technology heighten awareness environmental conservation decline birthrate aging population country mature economy addition new lifestyle work style base remote operation common drive covid pandemic otsuka group company create product service address consumer patient ryukangodo jissho sozosei need contribute resolution social issue carefully monitor change sweat recognize way actualization creativity process discover selfactualization pursue business environment market need order provide new value core substance achievement completion otsuka capable hard work discovery deliver unchanged mission focus otsuka value creation guide right practice truth th anniversary otsuka holding co ltd integrate report otsuka holdings co ltd integrate report message president production new thing leverage samscajinarcjynarque exist asset innovative way ryukangodo jissho blockbuster development involve trial sozosei interlink rethink creatively error overcome obstacle daily hypothesize implement carry pursuit achieve otsuka lead sozosei combination ryukangodo take root corporate culture jissho otsuka group q initiative take lead innovation perspective human resource business advance patient centricity digital foundation present predecessor innovation otsuka early adopter enable produce product cater unmet market need optimize clinical trial location patient large group company want realtime insight recruitment mentality employee change trial large diverse patient population advise think innovation patient centricity extend end identify opportunity problem product example approval north america innovative mindset group company astex pharmaceuticals second perspective system lead inqovi orally administer hypomethylate agent q basic policy corporate governance otsuka group new innovation end crucial actively enable patient receive treatment home promote communication inside outside hope otsuka company excite corporate governance key element take measure internal control group establish network discipline people outside look forward see institutional design internal control management group company include conservation area free fix idea culture otsuka introduce organization survive transparency asset information security business continuity encourage employee try new idea derive individual believe otsuka institutional design refer formulation planning consider legal compliance system fail important company individual pursue operation institution board director particularly crucial order operate diverse business learn failure apply learning challenge like audit supervisory board board world ensure compliance illustration perspective fortify organization lead innovation director otsuka holding hold vigorous discussion organizational structure education operate practice initiative pharmaceutical reflect different viewpoint include advance management transparency promote outside director diverse background proper governance system information disclosure q otsuka group need order continue sustainable growth operation business activity perform board accordance japan corporate governance member properly audit monitor code continue proactive dialogue close collaboration audit supervisory board investor external stakeholder otsuka group strongly commit quality social issue business word member internal audit department internal corporate governance page commitment begin word busaburo otsuka otsuka group mission contribute control department accounting auditor founder otsuka express calligraphy maintenance promotion people health launch intravenous solution business treatment disease attitude pursue quality vital factory resolution social issue q message stakeholder th anniversary packaging manufacture business match direction market put un sustainable development goal otsuka group company celebrate review business birdseye view consumer position recent year action address th anniversary september group flexibly adapt change necessary search commitment pass environmental issue sustain business operation century new possibility adapt new normal group quality regard company develop group company operate time demonstrate true value otsuka group signify important obligation set country region approximately unique total healthcare company satisfy new product quality quality goal tie materiality employee deeply grateful support need prepare stage value chain climate change resource recycling stakeholder enable achievement unchanged corporate philosophy otsukapeople entire group pursue quality conservation water conservation global economy society midst create new product well health worldwide management multiple endeavor achieve transformation covid pandemic amplify sincerely ask continued support guidance dimension sustainable society harmonize social issue uncover new issue stakeholder base corporate business growth environmental philosophy aim contribute conservation groupwide people health addressing collaboration otsuka holding co ltd integrate report otsuka holdings co ltd integrate report otsukas story billion launch lonsurf equelle launch jinarc rexulti launch abilify maintena launch bodymaint found chemical raw material manufacturer otsuka group steadily develop provide product lead resolution social issue relate establish otsuka medical device healthcare align societys expectation diversify business launch samsca launch abilify launch innersignal revenue performance nutraceutical consumer product business pharmaceutical business billion found otsuka seiyaku kogyobu launch futraful launch calorie mate launch pletaal launch ts start iv solution business launch oronine ointment launch pocari sweat launch uft launch mucosta launch internally launch oronamin c drink develop drug mikelan meptin launch world commercial retort pouch food start diagnostic product bon curry business establish pharmaceutical research institute diversification business aim resolution social issue high incidence shift social issue clinical nutrition medical need heat disorder nuclear family unmet medical need skin health issue public health satisfied pharmaceutical unbalanced diet diversify lifestyles stable supply development development development development minimally evidencebase development highquality iv sterilizer functional beverage retort pouch food provide total healthcare solution diagnosis treatment invasive medical device skincare product achieve solution disinfectant food product product specialize treatment iv solution oronine h pocari sweat calorie mate bon curry abilify samsca quick navi innersignal ulos biomimic ointment representative product medical pharma cosmedic device clinical cn eru tt icra ls c po rn os du um cte sr clinical ceutical consumer pharma diagnostic consumer diagnostic c po rn os du um cte sr diagnostic cosmedic nutrition otc nutrition product ceutical product diver oifi fcation chemical nc ul tin rii tc ioa nl otc nc ul tin rii tc ioa nl otc clinical cp eh ua tr m caa ls otc cp eh ua tr m caa ls c po rn os du um cte sr business chemical chemical clinical nutra otc nutrition otc nutrition certical clinical chemical cn eru tt icra ls chemical chemical cn eru tt icra ls chemicals nc ul tin rii tc ioa nl nutra chemical nutrition otc nutra certical chemical certical change fiscal year result fiscal month transitional period end december otsuka holdings co ltd integrate report otsuka holdings co ltd integrate report otsukas strength people source strength otsukas establishment employee page global reach incorporate solution social issue pursue business guide endure corporate philosophy order bring core business process health people worldwide determination employee develop strength strength describe representative sample continue extend global reach address social issue eg heat disorder infectious disease differ evolve day make well possible use strength employee new countryregion depend culture custom time go forward provide product service lead challenge fulfill potential order contribute well health worldwide resolution social issue countriesregion iv solution business overseas company endure corporate philosophy essence management passed practice group countriesregion pocari sweat available engage employee think act creatively preconceive countriesregion countriesregion notion support development embody tuberculosis drug deltyba available unique capability potential believe engagement corporate philosophy display corporate philosophy essence management reflect prominently office country corporate culture bring today build business page otsuka tomorrow ability nurture endure brand ryukangodo jissho sozosei develop brand uncease effort convey health value innovative product bear creative process discover selfactualization pursue research development ability nurture brand develop activity lead sustainable core substance achievement completion otsuka capable hard work discovery deliver growth enhance corporate value enable challenge find original approach new healthcare practice truth need topshare product pharmaceutical category page japan outside japan business model center total healthcare sustainable society share consumer experience provide variety sciencebase product service wes lo lc bi ea il n g pocari sweat meet specific healthcare need time community conceive product service physical mental wellbeing wellbee contribute year time area page physical social wellbee solid financial foundation strong earning power provide value drive sustainable growth bring health people worldwide cultivate solid financial foundation strong earning power nutraceutical iv solution generate stable earning act base therapeutic agent driver growth fund ongoing investment creative new area befit otsuka form basis sustain investment area create new value face change business environment page unwavere quest originality aa rating pursue creativity implicit corporate philosophy entire value chain research development business profit margin marketing ongoing challenge create innovative product service think generate kind nutraceutical business innovation define otsuka target unmet medical need yettobeimagined need consumer inhouse drug discovery ratio ratio inhouse drug discovery project latephase development project december unmet need area define otsuka base patientsmapjp patientsmapus ssri development project unmet need number company engage iv solution business company export product neighboring country make meaningful contribution medical care country psychiatry cardiovascular copyright iqvia create base annual category total past year include iqvia midas otsuka research category define otsuka oncology neurology renal system reprint permission january survey japan conduct otsuka project project project project rate investment information inc average previous year reference average operating profit margin sp food beverage select industry index constituent previous year otsuka holding co ltd integrate report otsuka holdings co ltd integrate report value creation model input corporate philosophy sustainability mission value creation process output outcomes human capital human capital employee approx enhance employee engagement japan approx enhance measure respect human right outside japan approx new technological revenue fiscal scientific development new concept billion hypothesis wealth technological relationship social capital scientific asset relationship social capital total group company expand product access product service japan enhance system realization outside japan pharma pharmaceutical business healthful life business site countriesregion ceutical nutra therapeutic drug clinical provide support covid pandemic chemical ceutical nutrition product diagnostic medical device stakeholder manufacture capi ta l diversify otc unique cosmedic create value nutraceutical business value provision manufacture capital manufacturing site need diverse product functional beverage functional consumer patient achieve stable supply highquality japan business service foods cosmedic otc drug healthcare professional product outside japan consumer clinical quasidrug employee business promote sustainable procurement product nutrition partner investor consumer product business shareholder intellectual capital diagnostic dee vd icic ea sl beverage food alcoholic local community intellectual capital beverages society contribute solution unmet need research site innovation japan business promote research development outside japan functional chemical fine partnership future health create new value chemical warehouse operation issue pioneer field transportation packaging overlap derive business electronic equipment financial capital financial capital niche field maintain sound financial foundation total asset billion deliver stable return shareholder total emission fiscal sustainability mission co ton natural capital natural capital water energy consumption increase utilization renewable energy kl conduct water resource risk assessment water consumption strengthen environmental management compliance ryukan jissho sozosei godo december data company include otsuka holding subsidiary affiliate company manufacture site consolidate otsuka group otsuka holdings co ltd integrate report otsuka holdings co ltd integrate report value creation process generate originality take challenge impact value creation capital otsuka capital impact value creation fy progress relate sdgs enhance employee engagement diversity promotion originality otsuka generate combination unique diverse business female manager ratio otsuka holding step otsuka group value creation process approach envision increase number employee take parental leave total human capital male future order anticipate need healthcare align societys expectation enhance measure respect human right try anticipate need arise change time environment way formulate implement otsuka group human right policy people think health leverage group strength consist unique march widerange business combine human resource extensive knowledge expand product access experience formulate hypothesis combine new technology scientific development country region tuberculosis drug deltyba available accumulate one create new value new product service launch adpkd drug jinarcjynarque country able create new value pioneer field overlap derive relationship region business way otsuka take challenge create new value social capital enhance system realization healthful life execute cooperation agreement prefecture japan possible total healthcare company promotion collaboration health awareness activity provide support covid pandemic donate relief good fund achieve stable supply highquality product establish begin operation tokushima mima factory otsuka new technological pharmaceutical new manufacturing site daiya food scientific development manufacture new concept promote sustainable procurement wealth technological capital revise otsuka group procurement policy september hypothesis establish otsuka group sustainable procurement guideline scientific asset september conduct supplier briefing supplier contribute solution unmet need innovation new drug launch pharma intellectual development project unmet need ceutical research development expense billion nutra capital inhouse drug discovery ratio chemical ceutical promote research development partnership sign joint research agreement new partner unique otc cosmedic create value diversify diverse maintain sound financial foundation product need credit rating aa service business financial capital business profit billion record high list consumer clinical deliver stable return shareholder product nutrition annual dividend share medical diagnostic device increase utilization renewable energy reduction co emission adoption renewable energy ton natural capital conduct water resource risk assessment assessment conduct manufacturing site company strengthen environmental management compliance create new value otsuka group acquire iso integrate certification future health issue pioneer field scope company otsuka pharmaceutical otsuka pharmaceutical factory taiho pharmaceutical otsuka warehouse otsuka chemical otsuka food otsuka pharmaceutical overlap derive development commercialization otsuka america pharmaceutical pharmavite otsuka holding otsuka medical device business cabpirin quick naviadeno ailamide viscoclear entrest inqovi quick navicovid ag enefluid injection unmet need area define otsuka base patientsmapjp patientsmapus ssri niche field ratio inhouse drug discovery project latephase development project strategic partnership taiho pharmaceutical astex pharmaceutical msd joint research otsuka pharmaceutical axcelead drug discovery partner strategic partnership taiho pharmaceutical md anderson cancer center license agreement taiho pharmaceutical peptidream otsuka pharmaceutical otsuka pharmaceutical factory taiho pharmaceutical include subsidiary okayama taiho pharmaceutical otsuka chemical otsuka food otsuka holding control company otsuka holdings co ltd integrate report otsuka holdings co ltd integrate report description materiality description mtm plan longterm fy goal contribute unmet need solution otsuka business fully synchronize effort address social issue grow achieve sustainability otsuka group approach sustainability guide corporate philosophy otsukapeople create new product well health promote business goal fiscal direction materiality worldwide otsuka group work contribute creation healthy sustainable mediumterm management plan fiscal society achieve growth pursue objective support comprehensive governance system determine material issue otsuka group society relationship materiality mediumterm management plan health people quality environment climate change resource recycling conservation water conservation governance announce goal pursue corporate philosophy entire group sustainability mission sustainability mission address social issue evolution healthy sustainable society simultaneously achieve growth activity support challenge new frontier promotion rd unmet need address unmet need psychiatry neurology area comprehensive governance system otsuka create firstinclass product oncology cardiovascular renal area contribution sustainable society development project generate innovation creative unmet need diverse research platform latephase development project advance phase provide deltyba generic delamanid eradication tuberculosis cumulative total case supply deltyba pediatric patient society healthy society environment healthy planet launch clinical trial new treatment regimen health people quality climate change resource recycling conservation water conservation increase access deltyba collaborate partner governance creation system challenge new category create new system reinforce exist corporate governance compliance risk management realization new area system realize healthy lifestyle healthful life create new concept product keep healthy life extension maintain highprofit structure process determine materiality material issue eye change environment materiality initiative otsuka focus issue discuss sustainability promotion determine otsuka group material issue committee approve otsuka holdings board compile list social issue reference range director meet result material issue international guideline framework include iso otsuka group determine society health people quality climate change resource recycling water conservation governance conservation gri un sdgs narrow people quality environment climate change list issue evaluate term resource recycling conservation water conservation importance take account ability contribute governance relationship materiality capital solution impact business strength relationship capital human manufacture intellectual financial natural identification social issue reference respective international guideline social materiality capital capital capital capital capital capital assessment social issue business activity contribute solve importance health society people determination material issue sustainability promotion committee viewpoint impact society otsuka group quality climate change approval otsuka holding board director meet environment resource recycling conservation sustainability promotion committee promote sustainability otsuka group committee responsibility include discuss decide direction plan sustainability activity otsuka holding director charge sustainability promotion serve committee chair committee member comprise group manager water conservation department relate sustainability sustainability officer company governance visit otsuka holding website map social issue httpswwwotsukacomencsrhdactivitymaterialityhtml otsuka holdings co ltd integrate report otsuka holdings co ltd integrate report materiality material issue fiscal goal fiscal progress otsuka group determine material issue base importance society social issue determine otsuka group materiality select issue group business society health people quality environment climate regard especially important present set goal relate fiscal change resource recycling conservation water conservation governance social materiality social issue goal activity relate sdgs goal fy goal fy progress issue unmet medical contribution unmet promotion rd unmet contribute unmet promotion rd unmet need area unmet need health need need solution need need solution address unmet need psychiatry neurology area new development project project create firstinclass product oncology area spread infectious eradication tuberculosis rd antituberculosis drug latephase development project project disease creation system improvement drug create firstinclass product cardiovascular renal area n utritional need realization access area unmet need new development project health ncrease age healthful life support awareness issue healthy life extension activity people health latephase development project advance phase maintenanceimprovement mainly exercise eradication provide deltyba generic delamanid eltyba nutrition etc tuberculosis cumulative total case provide deltyba cumulative total case promotion problem solve countriesregion supply deltyba pediatric patient strengthen partnership acquire indication deltyba children europe october launch clinical trial new treatment regimen rpharm acquire marketing approval deltyba russia p resenteeism creation corporate human resource development increase access deltyba collaborate implement supply global drug facility gdf stop tb society unprepared culture stimulate diversity promotion partner partnership alliance partner healthy diversification creativity healthful management participate pantb collaboration accelerate society people enhance employee development new tb treatment regimen engagement continue participation global health innovative technology ghit fund creation system challenge new category new area increase supply plantbase food product start operation new manufacturing site c onsumption gain stakeholder trust sustainable procurement realization create new system reinforce exist system execute cooperation agreement prefecture production pursue sustainability product design healthful life realize healthy lifestyle promote collaboration health field impairs level value chain thorough quality control create new concept product keep eye continue hold women health seminar sustainability establish quality stable supply change environment c ut mh u lan tn iviv ee tr osa tary l oo af tth st ru ek ga th rae na tlt sh ac po pm roic x l imib ar ta er ly quality assurance system safety responsible promotional activity start healthy president service security information provision deepen communication creation corporate instill corporate culture philosophy c reu sm ouu rl et iv de e vt eo lt oa pl mpa er nti tc pp ra gt rs mn st h oe f oex te sucu kati v ge l oh bu l c ademy stakeholder culture stimulate build system ongoing human resource oga promotion customercentric creativity development align change society cumulative total participant health seminar approx management enhance employee time engagement promote instill diversity source implement health safety measure employee covid pandemic g lobal warm fy goal reduce co emission innovation formulate otsuka group human right policy climate reduction co value chain emission compare fy pursue sustainability selfassessment questionnaire saq survey conduct cumulative total company implement saq change level value company company participate supplier briefing stable supply product covid pandemic chain ustainable procurement hold global production meeting environmental conduct supplier briefing supplier management information exchange meeting environmental load fy goal reduce environmental original goal timescompanie fiscal hold global product quality meeting increase reduction simple impact improve resource improve product base customer feedback environment resource incineration landfill efficiency recycling compare fy promotion business activity healthier high content aim sustainable state fy goal introduce renewable energy raise usage rate acquire iso integrate certification planet conservation r ac ty ecl iad l sa nd p ul ra pn et tb ba ose ttd l es society earth e sr ie od nu c ct oio mn p r ec cofree electricity e inx tp roa dn ud ce ed h coe gn etr ed ru atc oio nn yo sf ec mo af nr dee oel lae rc pr oic wity e r generation facility switch supply green power office department group fy company reduce fy goal understand water resource fy goal strengthen cooperation reduce simple establish otsuka group plastic policy water freshwater improvement water risk reduction simple incineration incineration landfill volume availability use efficiency management effective landfill compare fy build internal group system improve conservation water resource risk compare fy use water resource high content recycle usage rate recycle plantbase material plantbase material pet bottle f ragile governance longterm improvement strengthen corporate system corporate value governance fy goal improve water use efficiency accordance carry water resource risk assessment aqueduct social change risk thorough compliance improvement water use efficiency water resource risk unevenly distribute formulated water resource risk analysis chart manufacturing governance risk identification evaluation compare fy countryregion site identify watershed issue site management promotion rd build system strengthen compliance group ntroduce enterprise risk management july unmet need strengthen corporate governance raise effectiveness c arrie activity director raise effectiveness situation productivity poor condition mind body despite come work b uild governance system capable global business b oard director meet attendance rate development response change mplemente otsuka group global policy conflict interest unmet need area define otsuka base patientsmapjp patientsmapus ssri cumulative total tsuka advanced training healthy age supporter program support pharmacie health information hub strong connection local community december include carbonneutral electricity water resource risk assessment tool develop world resources institute otsuka holdings co ltd integrate report otsuka holdings co ltd integrate report sustainable society feature realize sustainable society unique total healthcare company social physical mental social wellbeing wellbee give climate change major social issue otsuka group develop market nutritional food longterm view earth health soybean japan traditional food culture refer otsuka group operate diverse healthcare business center pharmaceutical business physical mental meat field welcome daiya food nutraceutical business combination diverse business enable produce wellbeing wellbee canada otsuka group accelerate creative product value able contribute people health worldwide marketing plantbase food product global basis total healthcare otsuka deliver feature describe otsuka combine new technology knowhow acquire group create value combination diverse business process group diverse business provide new value address social need support revenue structure governance daiya otsukas soylution daiya food website httpswwwotsukacojpennutraceuticalabout httpsdaiyafoodscomwhoweare soylutionabout pharmaceutical business provide comprehensive creative product marketing value creation solution healthcare issue promote innovative initiative combine expertise experience combination diverse business psychiatry neurology cuttingedge digital technology abilify mycite world digital medicine facilitate monitor drug adherence important adapt change need time entail ongoing focus behavior patient expand available option issue relate change social environment include lifestyle change superage suitable therapy lead improved communication society unforeseen major disaster spread infectious disease need patient caregiver healthcare professional environmental conservation otsuka group provide continuous support address health psychiatry area text information make medical issue social need leverage strength total healthcare company record otsuka pharmaceutical ibm japan jointly develop mentat electronic medical record analysis deliver innovative product synergy continue develop sciencebase product saga solution analyze text information text mining effect nutraceutical research institute conduct research technology support identification optimal approach relationship soybean isoflavone women health patient otsuka group continue technology expertise accumulate iv solution addition research exercise nutrition particularly challenge develop new medical solution aim clinical nutrition product business basis focus equol ingredient produce daidzein improve quality life patient relieve burden place innovative product develop date metabolize intestinal bacteria develop facilitate recovery enhance communication example development pocari sweat inspire equelle dietary supplement support women health psychiatry area drug adherence management idea drinkable iv solution easily replenish beauty otsu nutraceuticals research institute conduct repeat relapse rehospitalization fluid electrolyte lose body similarly development research theme intestine nutrition lead issue face calorie mate inspire concentrated liquid food regimen development bodymaint utilizes plantderive life expectancy extend globally people conceive nutritional food product lactic acid bacteria b evidencebase efficacy health bear developed world live past age alternative iv solution rd project leverage management era year lifespan mental social knowledge production expertise relate group clinical wellbeing addition physical wellbee social nutrition product turn lead development equelle bodymaint environment lifestyle increasingly diverse unprecedented sciencebased product world otsuka group address issue improve form commercial retort pouch food product bon curry wellbee realize sustainable society develop apply sterilizationrelate technology electronic medical record psychiatry contain free description expertise accumulate production iv solution information difficult quantify eg medical history symptom information text mentat electronic medical nutraceutical business establish japans record analysis solution use natural language processing technology private research institute clinical exercise nutrition organize analyze electronic medical record psychiatry previously hinexr concentrate consider difficult aggregate database present information liquid food form useful medical setting hospital management forerunner calorie mate otsuka holdings co ltd integrate report otsuka holdings co ltd integrate report feature unique total healthcare company business structure achieve sustainable governance system global portfolio human resource familiar variety industry market management appoint outside director bring thirdparty enhancement corporate value viewpoint operation board director composition board director otsuka holdings global business support department establish include multiple executive director serve concurrently strengthen monitor operating company otsuka group diverse business operation play important role sustainable growth management team operate company board executive director charge business portfolio management include necessary respond change business environment section promote optimal groupwide investment strategy describe analyze risk opportunity perspective business structure corporate strategy aim maximize synergy underpin corporate governance page rapid relay information closeknit cooperation diverse discussion corporate governance page sustainable enhance corporate value total healthcare company history building revenue foundation diverse business foundation enable cooperation local community diverse business adaptation environmental change foundation otsuka group develop innovative pharmaceutical business nutraceutical business otsuka group promote communitybase health maintenance improvement initiative product ahead time lead resolution social substantially different business characteristic achieve disaster prevention relief activity describe activity support people issue relate healthcare continue grow sustainable growth respectively diversify risk health possible otsuka total healthcare company diversify business business diversity turn support business environment example pharmaceutical sustainable growth make group revenue structure business medical expense drug price reduce get close consumer deliver business nutraceutical business disaster prevention resilient risk ready act opportunity regard opportunity lead new value response provide local support closely align consumer otsuka group launch pocari sweat main advancement health awareness dissemination nutraceutical business apply knowledge need total healthcare company revenue source nutraceutical business addition selfmedication multifacete business platform expertise accumulate product include healthcare need vary substantially depend individual provide pharmaceutical information medical representative idea unique total healthcare company enable topic health promotion prevention lifestylerelate circumstance time region furthermore day cooperate group crossbusiness activity adapt rapid change business environment disease dietary education sport promotion disaster global covid pandemic substantially transform promote installation vend machine medical challenge envision future countermeasure promote contribution local community people lifestyle institution revenue earn nutraceutical opportunity risk pharmaceutical business conclude health cooperation agreement expect health issue business invest research development opportunity risk nutraceutical business prefecture japan agreement implement social issue pharmaceutical business tireless research development develop abilify antipsychotic launch revenue performance awareness activity health promotion provide speaker increasingly diverse lecture supply relief good event emergency complex otsuka group product contribute well health nutraceutical consumer product business worldwide way pharmaceutical business billion pharmaceutical business disaster recent year provide new specialized continue information concern pharmaceutical business addition development main revenue driver otsuka group nutraceutical preventive health information focus nutrition exercise futureoriente value business develop longselling brand recuperation provide support total healthcare creation focus continuously achieve business profit margin high company disease awareness activity help diverse business iv solution business engage healthy people stay healthy body mind present enhance longterm soon found maintain lead share mental care need increase plan support corporate value base japan support sustainable growth group mental health people local community leverage provision total stable revenue base support municipality strength psychiatry neurology area healthcare make market define otsuka copyright iqvia create base mat covid pandemic photo provide december jpm reprint permission addition combine initiative pharmaceutical social contribution suginamiku interbusiness communication governance work resolve diversify health issue consumer diversity source new idea innovation maintain consistency direction nutraceutical business continuously carry health awareness activity overall business management different market environment culture viewpoint value leverage asset acquire rd identify health key issue otsuka group operate global portfolio management structure otsuka issue dialog local resident continue relationship support holding core governance structure disseminate corporate philosophy resolve issue cooperation local community base relationships trust essence management ensure close interbusiness communication view create establish conclude cooperation agreement synergistic value diverse business prefecture japan new initiative complement partnership naoshi sato expert strength pharmaceutical business help resolve increasingly dissemination corporate philosophy senior vice president diverse consumer health issue era year life span sense philosophy business practice employee associate general manager essence management able identify social issue health issue include information world time executive management send nutraceutical division director societal health provide provide important adapt continually otsuka group pursue corporate philosophy otsuka proactive message concern corporate philosophy relation department change healthcare environment provide optimal solution people create new product well health worldwide essence management hand director promotion advertisement department continuously implement educational activity order historical management executive otsuka pharmaceutical promote understand dissemination corporate message president page otsuka holdings co ltd integrate report otsuka holdings co ltd integrate report message cfo framework financial strategy market complement cash earn global practice business management product cash invest sustainable rd aim awareness capital cost pursue sustainable return excess cost capital strengthen product pipeline psychiatry neurology oncology cardiovascular renal area growth enhance corporate value roic wacc investment target create new value answer unmet maximize business value make growth medical need include disease exist therapeutic cash flow generation cash allocation drug new concept integrate drug digital investment technology abilify mycite medical device business growth apply new approach ultrasound renal denervation profit operate investment reinvestment treatment cash flow yuko makino improvement capital refining manufacturing technology enhance product executive director cfo ccc expenditure quality implement rationalization measure iv solution otsuka holdings co ltd reduction business achieve stable cash creation japanese market nonoperate asset dividend shareholder link development overseas growth market return debt financing share buyback reinveste reallocate fund business area regional market nutraceutical business earn stable cash progress mediumterm overview attributable covid pandemic increase debt capacity major brand market mature reallocate fund plan revenue global product abilify maintena rexulti optimal capital structure create new category develop new region build overview plan samscajinarcjynarque lonsurf drive business brand strengthen manufacture marketing structure performance lead progress ahead plan mediumterm management plan position cash conversion cycle nurture brand make proactive investment continue work achieve plan target advance global market unique total healthcare promote value product measure adapt new normal company fiveyear growth phase provider total healthcare solution daily health pursue challenge target major brand pharmaceutical business nutraceutical business maintenance promotion diagnosis treatment pocari sweat nutrition sante brand nature maximize exist business value roic maximize exist business value create new value disease otsuka group emphasize social contribution nurture brand bodymaint equelle daiya management conduct business management corporate innovation ready challenge nutraceutical business fiscal line heighten wide awareness capital cost maintain sustainable second mediumterm management plan investment align corporate philosophy health awareness mainly regard disease prevention growth make growth investment ensure return advanced diversification revenue structure order help enhance corporate value social brand nutraceutical business favorably receive shareholder counteract patent expiration abilify lead contribution consumer select nature daiya product business profit fiscal set record high principle growth investment fund particular revenue daiya plantbase food product business progress list section tokyo stock exchange reinvestment cash return business increase fast market growth performance target pharmaceutical business nutraceutical business involve diverse product business performance recover level patent stable cash supply structure establish otsuka year period mediumterm management plan set business field make adaptable rapid change expiration factor relate covid group center europe north america japan increase revenue billion yen global product external environment contribute stable business operation pandemic include people stay home certain decision base achieve optimal capital structure billion yen new product schedule medium long term impact performance viewpoint business overreliance particular source funding take launch plan call revenue billion yen continuity situation renew appreciation consideration business risk credit rating expect rate return final fiscal year plan middle year fiscal importance diversity business portfolio combine investor factor secure diverse fiscal iv solution certain therapeutic drug mediumterm management plan pharmaceutical business nutraceutical business funding mean case impact covid pandemic affect reduce visit medical institution few surgical mitigating business risk emergency situation able prolong include issuance corporate bond commercial operation low hospital bed occupancy factor fiscal middle year mediumterm investment sustainable growth paper fund financial institution commitment management plan plan achieve revenue year set standard groupwide roic line billion yen revise downward initial cost capital addition measure corporate department support cost efficiency mediumterm management plan target billion yen maximize business return review improve smooth business operation establish groupwide business plan achieve business profit billion yen revise business asset efficiency set kpis accord business foundation specific activity include promote business fy upward initial target base growth characteristic furthermore introduce incentive link cost efficiency expand share service establish br uev sie nn eu sse profi b bi il li io n average annual growth rate fh b e eg nlo mba al k p inro gd su tec ats n pd r ot gh e n ssu traceutical business h rb ou gin os p ther ef gr rm oua pn c e th ew ree b yr e xs mill ii zn ig n gr exic ist ina gn ba ug se inm ee sn v alue cn ef nra test rr inu gct ou nre j f ao pr n n nm sn tau nfa dc ru dr ii zn e g pp uer ra chti ao sn in f th ne g nr oup roe high measure enhance corporate value framework financial strategy support new pra mu ofa tec stu ar sin seg ee ffp ica ir et nm ce yn bt ys rt eh vie e wco inrp cr ra ote ss se hp aa rr et hm oe ldn n gl ss w hich billion achieve goal mediumterm management value creation hold accordance japans corporate governance code plan maximize exist business value create new value mediumterm management plan aim utilize sell idle asset consider important strike balance organic maximize return cash basis optimize allocation basic policy shareholder return maintain stable growth exist business sustainable investment new investment focus balance sheet dividend emphasize continuity stability hig h er oorr hhiigghheerr v wa il du ee ac wre aa rt eio nn e sin os ft il cli pg b alu cs oin se ts h roa un ga hg oe um e thn et w oi tt sh u ka c rr op uo pra te mtr ae nn ag gt eh men ei nn tg p enro ad bu lic not g l ufe sc ty oc l le k da ig vee rm sie fin et pn rd fb itu ss tin rue cs ts u p reo r tt ofo lio di ev pid ee nn dd in g w oe n w pril ol fc ito n gs roid wer ha ad pit pio lyn ina gl ah cr oe mho pl rd ee hr e r ne st iu vern p proach enable maximize cash return exist business new growth investment secure sufficient cash return pursue growth investment allocate fund growth investment strengthen financial pharmaceutical business key strategy solid financial stand optimal capital structure foundation allow stable ongoing shareholder regard cash allocation generate additional coming year continue pursue business return return cash cost optimization control ratio sell capital efficiency promote measure business management e e general administrative expense product corporatewide awareness capital cost revenue business profit average annual growth rate roe announce otsuka holdings co ltd integrate report otsuka holdings co ltd integrate report grow detail healthrelate initiative visit advance unique total httpswwwotsukacomencsrsocietyhealth healthcare company otsuka group materiality set specific goal healthrelate social otsuka group operation encompass core business pharmaceutical business issue unmet medical health need spread infectious disease nutritional need provide comprehensive health support diagnosis treatment disease mediumterm management plan end fiscal measure nutraceutical business contribute maintain improve health healthy take resolution people go boundary conventional pharmaceutical company aim indispensable contributor people health worldwide leverage strength unique social issue unmet medical health need total healthcare company goal contribute resolution unmet need business strategy exist business value maximization new value creation fy goal fy progress strengthen strategic initiative growth driver global product pharmaceutical business promotion rd unmet need area unmet need major brand nurture brand nutraceutical business address unmet need psychiatry neurology area new development project project create firstinclass product oncology area latephase development project project launch nurture new driver sustainable growth pharmaceutical nutraceutical business create firstinclass product cardiovascular renal area area unmet need performance target business profit cagr new development project latephase development project advance phase organic growth mainstay product brand pharmaceutical nutraceutical business actively invest rd continue create new drug drive revenue unmet need area define otsuka base patientsmapjp patientsmapus ssri mediumterm management plan cumulative total revenue billion mediumterm social issue spread infectious disease management plan target business profit billion cagr fy goal eradication tuberculosis roe high fy goal fy progress p rovide deltyba generic delamanid deltyba progress mediumterm revenue business segment case provide deltyba case country management plan fy upply deltyba pediatric patient region launch clinical trial new treatment regimen acquire indication deltyba children europe overview fiscal increase access deltyba collaborate partner october rpharm acquire marketing approval deltyba russia fiscal second year mediumterm management plan covid pandemic certain impact take implement supply global drug facility gdf pharmaceutical business stop tb partnership alliance partner heighten health awareness growth opportunity leverage nutraceutical business participate pantb collaboration accelerate consumer business true value unique total healthcare company achieve billion yen development new tb treatment regimen business continue participation global health innovative technology revenue billion yen increase previous fund ghit fund year maintain solid growth furthermore business profit billion yen increase previous year set record high stock list social issue nutritional need goal creation system realization healthful life mediumterm management plan progress date announcement fy goal fy progress cagr billion e e challenge new category new area increase supply plantbase food product create new system reinforce exist system realize start operation new manufacturing site revenue healthy lifestyle execute cooperation agreement prefecture japan create new concept product keep eye change promote collaboration health field business profit rd environment continue hold women health seminar expense th anniversary otsuka health comic library rd expense cumulative total oathas registrant approximately launch kenko shacho healthy president service business profit roe higher high otsuka holdings co ltd integrate report otsuka holdings co ltd integrate report contribute resolve unmet need follow approval lonsurf pharmaceutical business additional indicational syndrome inappropriate trifluridinetipiracil anticancer agent antidiuretic hormone secretion siadh june back strengthen information provision treatment mediumterm management plan call progress global product jynarque launch option unresectable advanced recurrent colorectal cancer maximize exist business value create new value global product expand region add treatment adpkd effort raise disease awareness approval additional indication unresectable challenge new frontier otsuka indication overseas work increase awareness clinical trial datum available helped spread recognition advanced recurrent gastric cancer japan europe generate innovation creative diverse research convenient dosage formulation drug revenue fiscal disease drug lead steady increase prescription lonsurf increase platform advantage strategic framework rise previous year make considerable prescription europe jinarc sell approximately particular home treatment use oral anticancer position global productsabilify maintena rexulti contribution growth consolidated performance country number patient receive treatment agent recommend give covid pandemic samscajinarcjynarque lonsurfas growth driver drug increase lonsurf select oral therapy accelerate growth target increase revenue revenue plan global product new product maximize value currently pursue promotion line fiscal billion yen global product billion global product new product therapy clinical study treatment combination billion yen new product schedule launch e current mediumterm management plan billion otsuka group focus unmet medical health need social issue end fiscal begin new b il li n grow north american oncology business development project phase unmet need area approx taiho oncology strong year despite covid pandemic lonsurf sale grow project fiscal advanced latephase billion significantly metastatic colorectal cancer mcrc metastatic gastric cancer pandemic development project phase project fiscal help reveal value oral therapy treatment option cancer patient taiho unmet need area oncology launch inqovi market myelodysplastic syndrome multi aaa e e e e e e e e product commercial organization focus solid liquid tumor unmet need area define otsuka base patientsmapjp patientsmapus ssri rd mtm plan th mtm plan remainder mediumterm plan plan continue growth north timothy whitten america base follow potential lonsurf growth clinical trial lifecycle management plan study lonsurf treatment combination early course mcrc fy taiho oncology inc billion fy revenue yearonyear revenue plan growth rate president ceo complete initial inqovi launch potentially commercialize new compound originate inhouse discovery program aggressively look external neartomarket inlicense abilify maintena opportunity rexulti additionally development organization continue plan implement clinical trial focus exciting compound originate tsukuba research center samscajinarcjynarque lonsurf total deltyba abilify maintena samscajinarcjynarque otsuka group consider spread infectious disease social issue target eradication tuberculosis tb aripiprazole antipsychotic longacte injectable tolvaptan vreceptor antagonist infectious disease large death toll present day million people develop tb approx million die tb annually culmination year rd otsuka group develop deltyba global treatment schizophrenia increase samsca highly evaluate guideline japan world new tb drug half century december available countriesregion awareness drug efficacy claim convenient dosage prescription increase treatment cardiac edema important option patient multidrugresistant tb october approve additional pediatric formulation follow approval japanese hepatic edema prescription treatment autosomal indication europe eradicate tuberculosis major challenge worldwide support effort otsuka approval additional indication treatment dominant polycystic kidney disease adpkd intractable renal work expand access deltyba ship dose treat case bipolar disorder prescription increase disease increase owe promotion proper use guideline disease awareness activity drug rexulti supply stop tb partnership gdf february brexpiprazole atypical antipsychotic global operation adpkd drug participation access program implement country public international organization endtb program conduct united global health agency market adjuvant treatment major depressive disorder treatment schizophrenia drug highly access program implement government south africa india evaluate efficacy safety new treatment option access alliance partner disease japan drug market treatment alliance rpharm jsc russia cis etc schizophrenia prescription grow significantly europe launch approx contribute approx alliance mylan nv viatris inc india south africa highburden country sale begin april country patient access compassionate use program present clinical trial way aim supply patient country contribute treat unmet need psychiatry contribute approx neurology area patient public program provide exceptional access yettobeapproved drug detail tb initiative visit exceptional basis patient lifethreatening disease ghosh et al eur respir j nov httpswwwotsukacomencsrsocietyhealth estimate number adpkd patient pharmaceuticalhtml europe japan march inhouse survey otsuka holdings co ltd integrate report otsuka holdings co ltd integrate report future pharmaceutical business opportunity risk implement response medical cost inflation agitation associate dementia alzheimer type risk affect environment surround pharmaceutical issue worldwide despite risk otsuka estimate approximately million people estimate alzheimer disease think business operating include relate reduced visit group develop multiple pipeline multiple area order large number patient exhibit form behavioral disorder agitation excessive motor activity medical institution delay clinical development contribute resolution social issue initiative verbal physical aggression kind disorder place burden patient caregiver impact quality life global covid pandemic intensifying competition paradigm target disease high unmet need otsuka group aim market world treatment agitation associate dementia alzheimer type clinical shift treatment technological innovation policy trial way drug different mechanism action brexpiprazole rexulti avp hope therapeutic development project contribute physical wellbeing patient strength weakness mental wellbee social wellbeing include caregiver solution realization provide total healthcare solution diagnosis treatment management personnel advanced skill diversify sustainable society global rd marketing asset psychiatry neurology business drdecision resource llc right reserve reproduction distribution transmission publication prohibit area cardiovascular renal area strengthen portfolio management relate patent expiration presence oncology area mainstay product w stable profit iv solution business trength eakness originality free fix idea opportunity threat advance science technology progress basic global drug price control policy promotion generic drug research relate disease use medical cost inflation status psychiatry neurology pipeline creation synergy therapeutic drug advance intensify competition core area march digital technology restriction sale promotion activity strict regulation country development promotion precision medicione penha pnce eff rica tcy unity pandemic relate spread infectious diset aseshreat pipeline feature indication region status brexpiprazole dopamine partial major depressive disorder japaneurope phase iii agonist schizophrenia china phase iii agitation associate japanus future initiative focus psychiatry neurology oncology phase iii dementia alzheimer type europe pharmaceutical business promote measure cardiovascular renal area satisfaction current posttraumatic stress disorder phase iii resolution issue take challenge treatment method disease remain low aim new area otsuka resolve unmet need create innovative new drug unique approach borderline personality disorder phase ii generating innovation base creative diverse research leverage synergy diverse business schizophrenia longacte phase injectable platform aripiprazole dopamine partial bipolar disorder japan approve longacte injectable agonist schizophrenia china file opc serotonin major depressive disorder psychiatry neurology norepinephrine japan phase ii dopamine reuptake aiming topclass global player psychiatry neurology area inhibitor highpotential pipeline product portfolio avp nmda receptor agitation associate useurope phase iii antagonist serotonin dementia alzheimer type psychiatric disease schizophrenia bipolar disorder treatment establish norepinephrine reuptake inhibitor negative symptom phase iiiii major depressive disorder develop age affect cause mechanism fully understand make sigma receptor schizophrenia person social life career study discovery new drug extremely difficult otsuka group agonist traumatic brain injury phase ii concern increase alzheimer disease world enter psychiatry neurology area intermittent explosive disorder phase ii population age disease affect patient continue challenge new drug discovery quality life place strain family member goal contribute medical need centanafadine norepinephrine attention deficit hyperactivity dopamine disorder caregiver healthcare economy highpotential pipeline product lineup phase iii serotonin reuptake psychiatric neurological disease satisfactory aim topclass global player area inhibitor pizuglanstat pgd synthase inhibitor duchenne muscular dystrophy japan phase iii fremanezumab anticgrp antibody migraine japan file opc epilepsy phase development project unmet need area define otsuka base patientsmapjp patientsmapus ssri project advance fiscal approve september brand abilify prolong release aqueous suspension m injection otsuka holdings co ltd integrate report otsuka holdings co ltd integrate report oncology status oncology pipeline march maximize business value proprietary drug discovery platform initiative new development pipeline feature indication countryregion drug discovery technology methodology status approve taiho pharmaceutical broad portfolio support center external collaboration otsuka myelodysplastic syndrome proprietary drug discovery platform technology include pharmaceutical taking challenge establish new japan phase astx dna methyltransferase inhibitor proprietary biochemical modulation technology uniquely develop therapy focus future include create synergies europe phase iii history cysteinomix drug discovery technology new modality area genemodifie cell therapy acute myeloid leukemia phase enable specific covalent modification therapeutic target individual group company combine accumulate fragmentbase drug discovery technology establish astex asset field strength bolster global operation solid tumor lymphomas phase ii tolinapant iap inhibitor pharmaceutical company accelerate development enhance business value tcell lymphoma japan phase drug resolve unmet need work pharmaceutical platform discover compound cause specifically covalent bonding tolinapant iap inhibitior dna collaborator furthermore look opportunity reactive amino acid residue mainly cysteine residue protein potential acute myeloid leukemia phase astx methyltransferase inhibitor drug target protein collaboration promise startup corporate venture technology create new compound molecular design clarifie astx erk inhibitor solid tumor phase iii capital expand development pipeline cancer interaction smallmolecular fragment show pharmacological activity immunotherapy area acquire innovative drug measure highthroughput screen large molecule protein astx mdm inhibitor solid tumor phase iii complicated structure implicate disease discovery platform technology potential drug target astx dna methyltransferase inhibitor myelodysplastic syndrome japanus phase cardiovascular renal system chronic myeloid leukemia ponatinib bcrabl tyrosine kinase inhibitor china phase ii acute lymphoblastic leukemia create firstinclass product new drug discovery technology medical device diffuse large bcell lymphoma japan phase cardiovascular renal area addition strengthen unique medical device draw innovative technology opb hematological cancer phase proprietary drug discovery platform plan actively strength drug clinical research ultrasound renal growth investment example include denervation treatment new therapy expect decrease opb solid tumor japan phase business alliance akebia therapeutic vadadustat high blood pressure case effectively treat japanus ta dutpase inhibitor nonsmall cell lung cancer phase ii aurinia pharmaceuticals voclosporin acquisition exist drug ultrasound renal denervation system europe visterra company renal diseaserelate pipeline breakthrough device designation fda osteosarcoma japan phase iii otsuka group strive find solution unmet need aim create firstinclass product new drug pamufetinib multikinase inhibitor prostate cancer japan phase ii resolve drug advance development discovery technology medical device gastrointestinal stromal tumor japan phase iii pimitespib hsp inhibitor solid tumor useurope phase strength drug discovery otsuka pharmaceutical ta solid tumor japan phase otsuka pharmaceutical global satellite research structure site japan uk japanus cholangiocarcinoma phase iii europe china pursue drug discovery diverse modality include small molecular drug antibodie cell gene therapie company smallmolecular drug breast cancer useurope phase ii futibatinib fgfr inhibitor discovery platform create firstinclass drug central nervous system cardiovascular japanus fgfr aberration cancer phase ii system renal area addition astex uk acquire approval new europe oncology drug fragmentbase drug discovery base protein structural analysis urothelial cancer useurope phase ii toshiki sudo computational chemistry visterra engage antibody drug discovery base tas peptide vaccine urothelial cancer japan phase ii executive director proprietary antibody preparation technology otsuka pharmaceutical aim contribute research intellectual global healthcare create innovative drug open innovation academia tas prostate cancer useurope phase property biotech outside japan tas solid tumor useurope phase iii otsuka pharmaceutical ta solid tumor useurope phase status cardiovascular renal pipeline tas lsd inhibitor acute myeloid leukemia phase march tas solid tumor japan phase iii development pipeline feature indication countryregion status tas acute myeloid leukemia phase syndrome inappropriate trabectedin tolvaptan vreceptor antagonist antidiuretic hormone secretion japan approve yondelis ovarian cancer japan phase opc vreceptor antagonist cardiac edema japan file canerpaturev oncolytic virus pancreatic cancer japan phase file tbi nyeso sitcr gene therapy synovial sarcoma japan phase iii vadadustat hifprolyl hydroxylase inhibitor renal anemia europe phase iii tbi cd car gene therapie acute lymphoblastic leukemia japan phase iii vis antiapril monoclonal iga nephropathy japanuseurope phase ii chemotherapyinduce nausea ultrasound renal cauterization renal sympathetic fosnetupitant nk receptor antagonist vomit japan file high blood pressure japanuseurope denervation system nerve medical device development project unmet need area define otsuka base patientsmapjp patientsmapus ssri development project unmet need area define otsuka base patientsmapjp patientsmapus ssri project advanced fiscal project advance fiscal approve july brand inqovi approve june brand samsca otsuka holdings co ltd integrate report otsuka holdings co ltd integrate report nature nutraceutical business pharmavite lead company supplement retail multi lead sale share vitamin sale choice industry nature supplement brand pharmavite japan mediumterm management plan call revenue revenue plan major brand nurture brand pharmacist develop market product free flavoring coloring growth billion yen major brandspocari billion major brand nurture brand preservative lineup highquality supplement sweat nature nsand billion yen key item verify meet strict e nurture brandsbodymaint equelle daiya billion quality criterion set united states pharmacopeia usp b ase total retail sale aggregate datum report furthermore work maintain highprofit nature leading choice pharmacist scantrack service supplement vitamin category week period end december information resources inc structure capable sustained business profit margin ap p ro x billion selfmedication increasingly prevalent ntage sri health food multivitamin market cumulative market share higher create new product concept anticipation billion recent year related demand continue increase drive brand januarydecember change business landscape expand factor include medical cost inflation supplement news world report pharmacy time survey product category letter vitamin ae coenzyme q omegafish oil new category new region market continue grow cagr flax seed oil herbal supplement mood health supplement diabetic sale substantially increase multivitamin cholesterol managementnatural garlic supplement heighten health awareness aaa e e e e e e e e rd mtm plan th mtm plan mainly regard disease prevention yoy change nature revenue covid pandemic aim turn nature billion rd mtm plan yen brand develop product billion business profit leave new product global new business business profit margin incorporate cuttingedge science operation take challenge new category euromonitor international uk business profit margin nutrition sant ns maintain high organic food market europe grow recent half second half half second half year healthconscious consumer demand safe trustworthy food trend freefrom food build resilient business foundation health food product country nurture brand alternative product attract attention millennial world center europe generation fiscal european meatfree manufacturing site ns obtain iso iso food market worth approximately billion dollar nd mtm plan major brand grow rapidly past year cagr if certification international standard review management asset audit food manufacture conduct production glutenfree food market worth underpin value chain concern environment high level quality billion dollar e e management ns build new factory glutenfree expand cagr product france strengthen development free product meet evolve consumer need ns health progress major brand sport beverage market asiapacific nutritional food food product free specific ingredient food contain gluten pocari sweat million refer glutenfree product company provide euromonitor international uk retail value rsp overseas mainly asia sale volume pocari sweat beverage replenishing fluid electrolyte increase awareness activity tailor characteristic need region cagr asiapacific sport beverage market exclude japan pharmavite transformation continue th anniversary year period intend outpace recent market growth forecasting cagr overseas revenue pharmavite continue build future ahead mediumterm pocari sweat period mediumterm china indonesia thailand philippine vietnam management plan transformation accelerates shift new way management plan hong kong myanmar business model mindset stay true foundational value root science furthermore give high level health consciousness euromonitor international uk exclude japan quality mean business model transition historically retailfocuse company strengthen global sale structure expand leverage science unique moment consumer focus new region expect growth demand health proactive maintenance health wellness pharmavite seek meet need beverage pocari sweat jeff boutelle leverage science technology innovation leader preventative solution future aim grow pocari sweat overseas revenue plan ceo pharmavite llc occasion pharmavite th anniversary reflect founder philosophy billionyen brand enhance brand strength nutrition basis proactive maintenance health wellness focus cagr original marketing thoroughly communicate future bring gift health life nature megafood equelle product concept nurish nature brand euromonitor international uk otsuka holdings co ltd integrate report otsuka holdings co ltd integrate report progress nurture brand future nutraceutical business bodymaint opportunity risk issue utilize expertise hone pharmaceutical business bodymaint commercialize base research conduct nutraceutical business involve risk stagnation otsuka group develop original sciencebase product otsuka pharmaceutical theme intestine global economy covid pandemic intensify support person aspiration live healthy life nutrition exercise nutrition contain b competition diminish market japan population continue identify underlie health need examine proprietary lactic acid bacteria focus health management decline sluggish market unseasonable weather social issue develop business focus functional athlete expose risk relate intense training despite risk pursue solution emerge health beverage functional food product resolve need develop bodymaint jelly conditioning food support athlete sport trainer plantderive lactic acid bacteria b develop bodymaint drink conditioning beverage lactobacillus pentosus onricb plantderive lactic strength weakness contain b help replenish fluid electrolyte acid bacteria isolate fermentation type support proper hydration bodymaint drink expand value tea leaf traditionally consume northern thailand creative product marketing base scientific evidence management personnel advanced skill diversify isolated sanae okada professor emeritus tokyo university pocari sweat product longterm popularity business product line support health management agriculture efficacy confirm otsuka overseas business incorporate solution social issue brand development field take time consumer pharmaceutical core business process j gen appl microbiol w steady earning power trength eakness equelle equelle originate research conduct otsuka opportunity threat pharmaceutical saga nutraceutical research institute rise consumer awareness selfmedication prevention daily sluggish overall beverage market unseasonal weather women health research theme equelle contain female hormone health tandem medical cost inflation intensification competition core area entry new equol sell japan food product estrogen diversification diet competitor support women health beauty time age pandemic relate spread infectious disease bring physical mental change japan deploy pportunity hreat equol dedicated staff expert knowledge women health nationwide cooperation physician pharmacists equol healthcare professional convey importance equol ingredient produce daidzein soybean personal care woman experience physical isoflavone metabolize intestinal bacteria aspect mental change activity aim maintain otsuka pharmaceutical year soybean research future initiative goal develop provide world creative product improve health woman enhance quality life focus property equol saga nutraceutical rd site nutraceutical business investigate theme maintain improve people health back scientific research institute succeed isolate lactococcus otsuka pharmaceutical provide broad range information strain lactic acid bacteria produce equol publicize nutrition exercise unique viewpoint evidence concern nutrition women health website progress result variety research continue utilize expertise hone pharmaceutical business leader global research field medium daiya daiya food develop manufacture sell highquality saga nutraceutical research institute creative plantbase food product cheese alternative establishment japan private research dressing dessert brand daiya enjoy institute clinical exercise nutrition saga nutraceutical vegetarian people food allergy health research institute conduct rd field relate conscious millennial generation plantbase alternative market continue grow exercise nutrition women health health issue daiya food expand sale channel product lineup large controlledenvironment room japan mainly area cheese alternative core complete institute enable recreation hypoxic product mediumterm management plan environment equivalent find altitude plan achieve revenue cagr meter previously difficult recreate hightemperaturehighhumidity lowtemperature lowhumidity condition facility help advance research percentage people buy plantbase food sport nutrition verifying effect fluid environmental concern nutritional intake environment h ttpswwwfoodnavigatorusacom pt articleshifthoware consumersthinkingaboutplantbase eatingmattsonunveilsnewsurveydata otsuka holding co ltd integrate report otsuka holdings co ltd integrate report otsu nutraceutical research institute creation system realization healthful life otsu nutraceuticals research institute establish otsuka group focus nutritional need social issue pursue creation system advance research intestinal immunity particular realization healthful life focus intestine play key role overall health example institute research related enhance bodys biological barrier increase secretion support health productivity management raise awareness proper hydration immunoglobulin iga antibody play crucial role otsuka pharmaceutical launch kenko shacho healthy otsuka pharmaceutical website include information section mucosal immunity exploratory rd demonstrate lactic acid president community website management title protect heat disorder section present bacteria b heightens function mucosal immunity executive japan network access information content base japan sport association guidebook lower probability catch common cold service support health productivity management prevention heat disorder sport activity enhance service membership launch edition initiative heat disorder prevention website comprehensive measure health promotion people create collaboration weather forecaster work age collaboration local government association activity raise company organization awareness topic addition otsuka pharmaceutical factory sell os oral rehydration solution provide operational women health support oshiete kakure dassui iinkai organization expert womens health carry activity japan raise awareness way prevent treat dehydration spread accurate understanding mental physical critical change experience woman relate health issue solution issue provide broad information concern nutrition enhance women health otsuka pharmaceutical website oathas program develop otsu skin care research institute healthy age supporter target pharmacist provide health support local community enable participant otsu skin care research institute perform rd cosmedic acquire knowledge practical skill require want improve people health health support ensure skin bodys protective covering care focus ingredient amp substance otsuka health comic library find naturally body develop energy signal amp begin publish otsuka health comic library active ingredient support skin turnover encourages promote sound growth development health habit melanin excretion body contain main child generation produce editorial supervision product innersignal series ulo contain moisturize japan medical association japan society ingredient amp base otsukas proprietary formula school health endorse japan pediatric society product line steadily expand include moisturizer library seeks convey basic health knowledge child cover sunblock skin wash refresh sheet shampoo whiten topic makeup human body nutrition care grow brand offer total skin care broad easytounderstand manner medium comic_strip body head toe year choose different theme publish new volume adenosine monophosphate comic_strip donate elementary school special need maintain improve people disodium adenosine monophosphate ot adenosine monophosphate moisturizing ingredient school japanese school overseas public library daytoday health suppresse production melanin prevent skin blemish freckle goal nutraceutical business support maintenance improvement people health worldwide contribute long healthy life expectancy end address yettoemerge need social issue unique concept eye change global landscape challenge create new value expand new category region combine cuttingedge scientific technological development unique business model go forward respond healthrelate social issue continue implement health awareness activity bring issue forefront offering solution brand strengthen collaboration external institution otsuka holdings co ltd integrate report otsuka holdings co ltd integrate report achieve sustainability detail healthrelate initiative visit health people httpswwwotsukacomencsrsocietyhealth details peoplerelate initiative visit total healthcare company otsuka group aim contribute people health conduct httpswwwotsukacomencsrsocietypeople business operation pursuit corporate philosophy consider essential employee able work freely vigorously good health promote proactive measure enhance employee health work resolve health issue business operation initiative resolve health issue measure enhance employee health proactively provide information support establish workplace people treatment continue activity case taiho pharmaceutical working case taiho pharmaceutical seeking resolve unmet medical need cancer patient proactively provide information recognize employee precious human resource taiho cancer sensitivity individual experience worldwide taiho pharmaceutical promote discovery pharmaceutical aim establish workplace limited occasion come detailed taiho pharmaceutical perform proactive activity communicate development anticancer agent undertake diverse employee treatment cancer disease information portal site provide information concern product information proper use information healthcare diverse activity include support project aim address continue work organize inhouse system provide system consultation service available employee professional scientific impartial manner manufacturer challenge oncology area proactive information anticancer agent publish handbook anticancer consultation service promote awareness raise activity family develop cancer disease provision agent patient summarize mechanism volunteer human resource department include importance cancer prevention examination site action effect drug symptom time frequently occupational nurse public health nurse establish page share actual treatment experience employee support activity experience adverse reaction seek medical advice cancer patient work support team present worktreatment family deepen understand participation readyfor sdgs sdgs medication record sheet japanese support project lead system harmonize work identify requirement experience recognize matching platform provide corporation pharmaceutical company publish guide proper use treatment extend leave cancer patient eliminate significance work member taiho pharmaceutical anticancer drug healthcare professional present readyfor inc ceiling number leave consideration transfer provider anticancer agent continue proactively provide proper information path return job formulate guide recognition initiative receive gold prize support diverse project address challenge field follow activity oncology crowdfunde work support employee cancer consecutive year ally declaration formulate summarize information work support award cancer survivorship sponsor ally community distribution booklet employee cancer broadly disseminate workplace cancer survivorship private project commit supervise appearance support center national cancer information intranet human resource seminar cancer employment center hospital booklet target patient receive cancerrelate information portal site cguide r elevant employee change position possibility transfer cancer treatment aya generation adolescent young portal launch employee cancer disease close move japan position possibility transfer limited region adult teen family friend person system enable employee return job year leave live share information problem live japanese consider develop company special reason include cancer refractory disease designate national government occur treatment solution distribution booklet fertility preservation handbook fertility preservation handbook cancer patient think cancer patient think child provide consultation service truly need support system child manufacturer engage oncology area half century taiho supervise fertility preservation support survivorship support pharmaceutical culture warmly support employee cancer disease department cancer institute hospital jfcr strengthen employment support revise employment rule documentary film thing know system enhance consultation service type symptom disease cancer patient screen free kitajima plant style cope vary individual endeavor good possible effort sincerely pursue support truly need employee akira mita deputy director human resource department taiho pharmaceutical communicating value health broadly continuously maintain improve health employee familie otsuka holding publish otsuka health comic library disorder common raise otsuka holding undertake activity promote employee women health conditioning immunity year communicate mechanism body awareness proper hydration promote dietary health cooperation otsuka pharmaceutical health approximately participant total disease health easytounderstand manner education communicate importance nutritional balance insurance association healthcare professional seminar hold online covid donate elementary school public library japan maintain promote womens health provide health management personnel pandemic nutraceutical business develop sciencebase information disseminate correct knowledge concern physical group company activity include health otsuka pharmaceutical open product provide information leverage knowhow mental change women health solution seminar group employee family inhouse seminar education support pharmaceutical business idea heat base knowhow expertise acquire rd base knowledge group business start concern alcoholrelate issue leverage soybean product seminar hold annually knowledge pharmaceutical business major city japan theme december health seminar ssenisub lacituecamrahp ssenisub lacituecartun otsuka holdings co ltd integrate report otsuka holdings co ltd integrate report detail quality dorelate initiative visit quality httpswwwotsukacomencsrsocietyquality help build sustainable society otsuka group guide endure philosophy customer quality pursue quality stage value chain promote initiative take account environment society human right production quality research procurement control patient logistic sale marketing customer service development customer safety ethical consideration sustainable procurement groupwide cooperation control maintenance appropriate promotion sincere response inquiry accordance law corporation business customerfirst qualityfirst product quality business enhance information access reflection company guideline collaborator otsuka group comply law continuity planning deliver highvalue product service activity rd time necessary apply entire value chain otsuka regulation administrative instruction healthrelate company customer group company otsuka group establish dedicated methodology verify efficacy group engage business activity industrial standard ensure rigorous control maintenance formulate observe code customer contact point staff safety otsuka group comply compliance law regulation work iso iso fssc product quality distribution practice expand jpma specially train personnel response certify addition observe law relate law ordinance respect environment pharmaceutical food product promotion code prescription drug inquiry match characteristic regulation country perform guideline strive uphold human right new supplier beverage furthermore transport establish expert panel drug quasidrug food product quality control quality assurance base bioethic scientifically valid transaction determine gxp implement postmarkete safety pharmaceutical register vehicle comprise people respective product opinion methodology viewpoint carry diligence control establish global safety authorize access restrict area department perform review request product service preservation environment safety business collaborator entire surveillance system collect monitor emergency exchange mous marketing plan sale promotion share group management otsuka group promote sustainable safety information concern adverse event shipper warehouse owner material purpose product development collaborator transport disaster procurement aim realize gxp good x practice general term good practice improvement system business continuity standard ministerial ordinance regulation guideline sustainable society establish government public institution plan ensure safety reliability promote sustainable procurement group drug healthcare information provision activity expect promote sustainable procurement activity otsuka group establish employee otsuka sustainable procurement task force otsuka holding otsuka fiscal covid pandemic collect information person difficult pharmaceutical otsuka pharmaceutical factory taiho pharmaceutical otsuka chemical otsuka otsuka pharmaceutical conduct timely information provision activity online ensure food otsuka packaging industry otsuka techno en otsuka pharmaceutical task force access drug healthcare information need ensure thorough infection formulate otsuka group procurement policy otsuka group sustainable prevention procurement guideline conduct survey sustainable procurement activity business partner drug therapy expect employee otsuka pharmaceutical continue yasunobu harada collaborator selfassessment questionnaire saq inhouse training give kazumi goto appropriate information provision activity ensure compliance come project office task force launch covid pandemic meeting session hold st lukes international university idea information provision online tool channel procurement exclusively online discussion vigorous director pharmacy department st otsuka holding luke international hospital kind wild bird come visit biotope tokushima itano factory season biotope promotion customercentric management inhabit insect include dragonfly october otsuka group announce declaration customercentric commitment way put corporate butterfly clean cool water philosophy practice promotion customercentric management group materiality mediumterm water scorpion dragonfly beetle factory recycle pour pond management plan conduct business recognize respect consumer right important human right issue frog water scorpion animal declaration customercentric commitment establish basic policy state commitment social responsibility live ground biotope area cover corporation fulfill pursue customercentric management make appropriate decision base dialogue leaf mold raise beetle larva stakeholder biotope compound form german word bio life hare daurian butterfly place signify place indigenous wildlife redstart flourish nature otsuka holdings co ltd integrate report otsuka holdings co ltd integrate report present example measure take value chain measure business collaborator aim sustainable procurement global initiative production department product quality department entire value chain otsuka group engage business effort update otsuka group procurement policy production department otsuka group employ traceability otsuka pharmaceutical product quality operation activity safe reliable socially acceptable compliance take account factor human right labor issue system cover stage value chain raw material pharmaceutical business nutraceutical business jointly hold law regulation commence transaction environment anticorruption measure formulate procurement production distribution sale enable annual global product quality meeting meeting supplier perform screen check ensure quality otsuka group sustainable procurement guideline provide thorough management entire supply chain attend approximately manager quality supervisor raw material guarantee stable procurement japan specific description provision vision year global production meeting pharmaceutical nutraceutical countriesregion conclude basic transaction agreement case new policy share business collaborator hold aim enhancement production technology include japan participant share company measure supplier transaction determine carry order ensure stable supply product perform share information groupwide plant manager future business expansion approach product diligence advance risk assessment key raw material clarify nature meeting hold virtually discuss challenge inspection amid covid pandemic aim mutually sustainable development fair potential risk countermeasure measure stable supply occupational health safety addition quality performance award establish equitable transparent procurement establishment sure source raw material multiple company covid pandemic meeting approximately recognize quality control initiative effort healthy relationship business collaborator principle participant include management executive train people quality control raise awareness countriesregion otsuka group procurement policy reflect customer feedback otsuka group company accordance corporate vision otsukapeople create new product group company establish dedicated customer contact feedback redesign container easier open well health worldwide international norm conduct procurement activity responsible way otsuka point patient healthcare professional general effort develop improved easiertouse product deliver innovative safe secure highquality product order contribute construction maintenance consumer provide appropriate training employee recognize good design award sustainable society health people world relate department approach help deepen furthermore enora liquid eternal use communication customer provide appropriate information adopt package design take consideration variation relationship supplier reflect customer feedback suggestion product color vision user product line receive cud collaborator supplier otsuka group aim build good relationship mutual sustainable improvement certification make easy tell product variation apart development share understanding base fair exchange appropriate information opinion product improvement os os jelly expect help improve patient adherence reduce supplier selection produce otsuka pharmaceutical factory product risk medication error healthcare professional otsuka group select supplier fair transparent manner base comprehensive assessment supplier food person medical condition receive feedback thirdparty certification ensure product color scheme easy elderly individual customer receive treatment people understand quality cost quantity delivery term compliance law regulation promotion environment preservation etc dherence refer patient actively understand meaning significance need nursing care say difficulty treatment take medicine correctly discontinue medication responsibility society opening cap muscular strength issue base accord realization sustainable society otsuka group strive maintain procurement activity reflect consideration human right labor environment nontolerance corruption compliance otsuka group company observe applicable law rule otsuka employee supplier employee act time high level ethic consistent social norm otsuka holdings co ltd september otsuka group effort promote sustainable begin presentation business collaborator share procurement otsuka sustainable procurement task force detail procurement policy company otsuka holding group company participate year conduct common saq form task force member take step prepare global compact network japan provide feedback promote group overall sustainable procurement include relevant company end receive revision procurement policy formulation sustainable questionnaire response company procurement guideline conduct saq presentation otsuka pharmaceutical otsuka pharmaceutical factory taiho pharmaceutical otsuka business collaborator chemical otsuka food otsuka packaging industry otsuka techno en otsuka pharmaceutical add march otsuka holdings co ltd integrate report otsuka holdings co ltd integrate report detail environmentrelate initiative visit environment httpswwwotsukacomencsrenvironment global group contribute health people worldwide otsuka group work introduce co free electricity green introduce solar power generation system sincerely reduce impact business global environment seek power certificate inhouse consumption contribute creation sustainable society protect nature future otsuka group introduce cofree countermeasure climate change otsuka group earth support solution social issue relate global environment otsuka electricity renewable energy source extend set goal reduce co emission group formulate environmental policy activity guideline determine use manufacturing site fiscal reduce co goal promote utilization emission approximately ton equivalent annual renewable energy improve energy use efficiency materiality environmental initiative climate change resource recycling emission approximately household introduction cogeneration system include solar conservation water conservation set goal carry activity introduction renewable energy power cofree electricity generation system aim achieve addition domestic group company purchase introduce solar power generation system green power certificate switch green power inhouse consumption kushiro factory otsuka sale site headquarters group company pharmaceutical factory otsuka pharmaceutical india goal goal fy reduction co emission compare fy japan office reduce co emission estimate result annual co emission reduction approximately tonsyear approximately kushiro factory otsuka go forward group work pharmaceutical india climate change fy ic tr e dm ucis ts ii oo nn fr e rd eu nect wio b lt eh r eo nu eg rgh co emission scope co emission scope realization decarbonize society ultimately otsuka group compare fy co emission japan overseas result tco tco tco sustainable society optimize maximize energy use introduction renewable energy fuel conversion exercise synergistic effect group company goal fy reduction simple incineration landfill compare fy include carbonneutral electricity utilize certificate equal renewable energy goal goal fy high content recycle plantbase material emit co pet bottle calculate co emission residential sector fiscal otsuka pharmaceutical otsuka pharmaceutical factory taiho pharmaceutical kushiro factory otsuka otsuka pharmaceutical india resource otsuka chemical otsuka food pharmaceutical factory recycling total waste volume simple incineration landfill fy conservation result evaluate water risk manufacturing site waterrelate risk group business activity consider environmental risk region important formulate analysis record site implement sustainable growth diverse business model comprehensive risk assessment utilize detailed water goal goal fy improvement water use efficiency compare fy otsuka group operate world datum collaborate group company pursue otsuka group conduct primary water risk assessment water resource conservation improve use efficiency water consolidated manufacturing site water risk identify regional risk promote specific research conservation fy water usage water use efficiency water resource risk assessment assessment tool aqueduct develop world resource collaboration group company take result million manufacturing site company institute wri understand minimize impact measure regionbase management effective utilization base performance manufacturing site consolidate otsuka group aqueduct water stress map breakdown region water consumption region otsuka group scope direct emission scope indirect emission energy source scope indirect emission otsuka pharmaceutical otsuka pharmaceutical factory taiho pharmaceutical otsuka chemical otsuka food acquisition integrate iso certification otsuka group otsuka group iso certification acquire group major company japan otsuka holding work acquire certification supervising organization acquire iso integrate europe manufacturing site group certification august integrate environmental company promote activity goal management system outline certification achieve environmental goal strengthen environmental initiative japan set company groupwide effort achieve goal north increase severity environmental acquire tokushima factory otsuka chemical present tokushima factory america water stress issue recent year company otsuka chemical tokushima factory otsuka food east asia high cquire certification company japan overseas december call contribute high otsuka pharmaceutical otsuka pharmaceutical factory taiho pharmaceutical south asia resolution issue north africa moderate high include subsidiary okayama taiho pharmaceutical otsuka chemical strengthen groupwide effort otsuka food low moderate southeast south efficient effective asia america low environmental activity otsuka use dry low water datum source wri aqueduct otsuka holdings co ltd integrate report otsuka holdings co ltd integrate report measure covid entire world force mobilize novel viral threat otsuka group implement measure prevent spread place priority safety health express deep condolence love one people lose live stakeholder covid extend sincere sympathy person infect virus family affect person thorough implementation infection sale marketing ongoing initiative maintain support activity prevention measure major group company pharmaceutical business improve health japan provide pocari sweat bodymaint calorie employee continue work safely enable continuous provision information healthcare new normal environment otsuka group mate os otsuka group product medical covid pandemic otsuka group introduce new work professional restriction visit medical continue initiative support resolution local health mask protective suit local government style system include telework implement appropriate institution pursue hybrid approach combine real issue activity communicate importance health relate organization infection prevention measure urge employee world digital eg enhance digital promotion maintenance promotion event overseas addition provide beverage food wideranging lifestyle change strengthen online access healthcare professional suspend postpone pandemic otsuka product pharmaceutical donation local introduce smartphone app pharmaceutical provide innovative support medical facility red cross example measure business continuity information provision example interhigh school usbased sozosei foundation donate total stage value chain otsuka group customer service competition season provide pocari sweat dollar approximately million yen organization work increase operational efficiency include promote pharmaceutical di operation telephone inquiry update information concern measure heat disorder relate mental health kidney disease charitable diverse flexible work style digital transformation take staff work home ensure business physical condition management exercise order organization accelerate initiative new continuity support medical setting time support high school student enable safe substitute public interest foundation establish otsuka carry normal contribute people health worldwide restriction visit medical institution contact center competition prefecture activity accordance otsukas sustainability mission include awareness activity mental health kidney disease disaster relief contribution award initiative otsuka pharmaceutical factorys dubai singapore indonesia otsuka pharmaceutical local community clinical development intravenous drug information center receive bcp award cohoste pocari sweat virtual run running event group company strive minimize delay recognize sustainability stability center utilize smartphone app collaboration national pandemic cause clinical study example measure di drug information operation pharmaceutical information management operation government addition online seminar communicate otsuka pharmaceutical include launch fully remote n award program initiative contact center determine assessment importance hydration exercise otsuka personnel review panel participate firm organize center japan editorial clinical study department ric telecom co ltd coorganized epartners inc work nutraceutical pharmaceutical field provide information help address issue relate lack exercise production quality control patient mental health customer safety formulate covid infection prevention control manual implement thorough infection control measure regular check body temperature stagger lunchtime otsuka pharmaceutical regard responsiveness avoidance cs closed space crowd place covid pandemic social closecontact setting enhance business continuity responsibility september planning develop laborsave technology comarketed quick navicovid ag rapid measure maintain stable supply system additional measure diagnostic test kit confirm test result ensure stable supply otsuka pharmaceutical placing minute advance order raw material evaluate second vendor manufacture comarketed denka company limit increase stock raw material product quality department otsuka group promote thorough measure maintain improve quality maintenance project combine blue color pocari sweat virtual run seeitblue global campaign mental health ensure safety management accordance business makeitblue aim increase awareness mental health crisis characteristic company example otsuka amidst covid pandemic singapore pharmaceutical replace direct visit remote auditing support municipality covid pandemic photo provide manufacture site contractor video footage suginamiku site otsuka personnel range role multiple location japan able participate verification process contribute energized communication quality improvement otsuka holdings co ltd integrate report otsuka holdings co ltd integrate report detail governancerelate initiative visit governance httpswwwotsukacomencsrgovernance shareholder meet corporate governance electsdismisse electsdismisse electsdismisse otsuka holdings co ltd company commit promote sustainable increase corporate value medium long term realize corporate philosophy otsukapeople create new product well health worldwide meet corporate consult board director ap cce ora ut nio tin na gl aa uu dd ii tt ss audit supervisory board commitment adopt basic policy make transparent fair timely decision fulfil corporate social governance recommend director outside director eu mdi bt e r ss u p oe fr v wis ho ory b ao ra er committee appointsdismisse outside member responsibility living expectation stakeholder include customer business partner employee local community shareholder ongoing dialogue president representative director ceo cooperate cooperate accounting audits instruct report account auditor company disclose basic approach corporate governance corporate governance guideline available corporate website internal audit department cooperate corporate governance guideline corporate governance report april httpswwwotsukacomencsrgovernancepdf httpswwwotsukacomjpcsrgovernancepdf approval meeting prior governanceguidelinepdf governancereportpdf available japanese material matter group board consultation management corporate ex post guidance auditor facto report overview corporate governance structure governance structure march subsidiaries shareholders meeting board director audit supervisory board member etc aim promote sustainable growth company company audit form organization increase corporate value medium long term supervisory board board director audit supervisory board member board director include outside director advance director outside director independent director board director convenes regularly month hold audit supervisory board member attend express opinion execution management plan supervise company management order enhance profitability capital term director year extraordinary meeting necessary important business meeting board director monitor performance decision supervise execution operationsto clarify dutie director term legal compliance soundness investment efficiency company secure soundness audit supervisory board executive responsibility fiscal year term director management audits strive improve establish solid corporate governance structure live member outside audit independent director social expectation ensure audit supervisory supervisory board member set year effectiveness audits audit supervisory board member share information exchange opinion appropriate board member independent accounting auditor kpmg azsa llc corporate governance committee relevant department include internal audit department director audit director performance duty note eloitte touche tohmatsu llcs term office company accounting february company establish corporate internal control department administration department collaboration accounting auditor internal auditor expire conclusion annual shareholder meeting hold governance committee aim increase transparency finance accounting department accounting audit department march meeting kpmg azsa llc elect new accounting auditor objectivity management advisory body board auditor initiative strengthen corporate governance director committee discuss matter relate corporate governance include nomination director audit internal audit department establishment otsuka holding outside director outside audit supervisory board term director set year member supervisory board member remuneration system company internal audit department report directly decision adopt director retirement benefit system effectiveness board director evaluate remuneration standard director report result president department regularly conduct audits base corporate officer system adopt system grant stock option conditional progress outside audit supervisory board member mediumterm management plan introduce deliberation board director committee consist internal audit rule verify operation execute outside audit supervisory board member corporate governance guideline revise president director charge administration appropriately efficiently regard asset business stock option performancelinke remuneration introduce corporate governance committee establish outside director march president serve company affiliate company department stock publicly list december start evaluate effectiveness board director base questionnaire complete director audit chair committee submit audit report president director audit mediumterm management plan announce supervisory board member supervisory board member need improvement outside director outside audit supervisory board start hold reporting meeting outside director member outside audit supervisory board member improve content deliberation department recommend remedial action later confirm understand group management business nomination implementation contribute optimization second mediumterm management plan announce outside director outside audit supervisory board female director corporate governance committee discuss validity business execution department share information member corporate governance guideline revise fairness matter relate appointment cooperate audits audit supervisory board member otsuka group global code business ethic establish mediumterm management plan announce otsuka group global anticorruption policy establish restrict stockbase compensation plan introduce dismissal director audit supervisory board member account auditor corporate governance guideline establish outside director female director report board director candidate internal whistleblowing system otsuka holding major otsuka group global policy conflict interest establish audit supervisory board member committee obtain internal control department group company establish report independent body outside company approval audit supervisory board prior report company view internal control integral component board director corporate governance function compliance composition board director committee candidate forward representative risk management establish internal control board director audit supervisory board corporate governance committee directors department department charge compliance risk ratio independent outside director ratio independent outside audit ratio independent outside director remuneration management improve internal control system supervisory board member corporate governance committee discuss matter internal control department promote otsuka group relate remuneration system remuneration standard global code business ethic otsuka group global rule director audit supervisory board member otsuka holding affiliate company work report board director establish promote compliance program risk management director director director addition committee deliberate matter relate program company status establishment enhancement corporate governance structure operation program regularly report board report board director necessary director audit supervisory board accounting auditor otsuka holdings co ltd integrate report otsuka holdings co ltd integrate report remuneration director audit skill matrix director audit supervisory board member internal control department handle internal control supervisory board member financial reporting company affiliate order establish effective corporate governance structure support sustainable growth company appoint individual widerange business experience advanced expertise broad field extensive knowledge director audit supervisory board company department formulate rule manual company remuneration plan director audit member table summarize area experience expertise director audit supervisory board member pertain internal control provide training ensure supervisory board member design achieve sustainable employee thoroughly understand operational rule growth enhance corporate value medium long global technology strategic finance legal company healthcare major department work cooperation internal audit term group base corporate philosophy rd planning compliance risk administration qualification business production marketing sale accounting management analysis public health etc department continuously monitor status operation ensure function business execution basis internal control system management management supervision exercise appropriately maintain ichiro otsuka personnel reliably evaluate transparency fairness tatsuo higuchi evaluation effectiveness board director remuneration level yoshiro matsuo january february year company conduct consider need acquire motivate outstanding yuko makino questionnaire survey director audit supervisory personnel responsibility company global shuichi takagi board member result survey review company business activity company set remuneration level fully sadanobu tobe attorney review evaluated board commensurate role responsibility expect director meet march personnel consider level company director masayuki kobayashi questionnaire item follow company consider benchmark base scale industry noriko tojo composition board director business model makoto inoue director understand knowledge business field specific management strategy plan remuneration system yukio matsutani md cooperation outside director regard remuneration director responsible business ko sekiguchi cooperation audit supervisory board execution company formulate remuneration system yoshihisa aoki operation board director meeting closely link performance individual fiscal year mayo mita governancerelated matter medium long term emphasize function board director determine sustainable enhancement corporate value remuneration yozo toba direction management strategy consist fix remuneration basic remuneration performance audit supervisory hiroshi sugawara cpa ii monitoring business respect execution link bonus sharebase payment emphasize link board yoko wachi attorney management strategy shareholder value remuneration outside director audit member iii understand perspective major investor supervisory board member comprise fix remuneration kazuo takahashi stakeholder basic remuneration light duty iv risk management rationale selection outside director outside audit supervisory board member v cooperation information share operating method determine content company remuneration individual director attendance rate support system outside director board director receive recommendation audit rationale selection board overall function board director appropriateness remuneration system remuneration supervisory director board perspective effectiveness level performance evaluation performancelinke meeting meeting bonus sharebase payment corporate yukio matsutani mr yukio matsutani abundant experience extensive knowledge healthcare governance committee consist president welfare field high level expertise overall health care provide appropriate valuable suggestion advice company management summary evaluation fiscal director charge administration outside director independent standpoint outside director objective expert viewpoint overall opinion improvement base recommendation board determine ko sekiguchi mr ko sekiguchi abundant experience track record extensive knowledge corporate previous year believe board individual remuneration director follow manager high level expertise network pharmaceutical business provide appropriate valuable suggestion advice company management director functioning appropriately standpoint outside independent standpoint outside director objective expert viewpoint effectiveness nonetheless result confirm need president delegate decide specific payment director yoshihisa aoki mr yoshihisa aoki abundant experience track record extensive knowledge improvement area role amount individual fix remuneration basic remuneration corporate manager abundant experience expertise network food industry provide appropriate valuable suggestion advice company management company hold company methodology director individual performancelinke bonus independent standpoint outside director objective expert viewpoint monitoring subsidiary approach cooperation director exclude outside director pursuant resolution mayo mita ms mayo mita securities analyst abundant experience corporate analysis base group company board director accordance delegation high level insight objectively observe analyze company provide appropriate valuable suggestion advice company management president make final decision remuneration amount independent standpoint outside director objective expert viewpoint base deliberation report corporate governance hiroshi sugawara mr hiroshi sugawara specialized knowledge certify public accountant abundant committee remuneration level outside experience knowledge business area audit yoko wachi ms yoko wachi wellverse corporate legal affair specialize knowledge insight individual sharebase payment director exclude supervisory base abundant experience attorney board outside director determine resolution board kazuo takahashi mr kazuo takahashi hold major position internal control department year member abundant experience knowledge corporate management director base report performance evaluation etc corporate governance committee outside director outside audit supervisory board member give risk conflict interest general shareholder company believe outside officer qualify independent directorauditor otsuka holdings co ltd integrate report otsuka holdings co ltd integrate report content remuneration director exclude outside director total remuneration director audit supervisory board member content remuneration director exclude outside director list total total type remuneration million number remu tyn pe eration pa fy ixm ee dn vt riae bth leod include policy deter mm inu ne gr tit mio inn gc r ce not dition remuneration classification mre m lliu ne r oa ft yo en n remuf nix ee rd tion sh pa ar ye mb ea ns ted bonus eligible officer fix remuneration director hold company determine base duty responsibility include director formulation group strategy monitor group operation strengthen corporate governance outside director fix cash remuneration director serve concurrently director subsidiary operate company determine base duty responsibility include execution business base group strategy formulate otsuka remuneration fix holding formulation strategy operate company strengthen corporate governance remuneration audit supervisory board member shall exceed upper limit remuneration resolve shareholder meet outside audit supervisory fix remuneration pay equally month board member remuneration pay lump sum certain timing fiscal year calculation method determine total performance cash base rate achievement fiscal year target consolidated revenue consolidated operating profit outside director audit consolidated business profit rd expense progress respect mediumtolongterm consolidated supervisory board member link bonus variable performance target appropriate business management compliance corporate governance individual personal performance director company concurrently serve employee current fiscal year outside director audit supervisory board member receive total remuneration million company subsidiary service company introduce sharebased payment plan reflect progress achieve target director audit supervisory board member mediumterm management plan cover period fiscal fiscal plan restrict stock allocation agreement stipulate condition include transfer restriction set period noncash conclude grantee plan design function effective remuneration system combine sharebased multiple release condition transfer restriction include set performance evaluation period performance restrict stock payment achievement principle grant restrict stock require evaluation performance fiscal year sustainability management structure otsuka holding variable time fiscal year specific timing grant restrict stock fiscal year item require evaluation performance single fiscal year time fiscal year evaluation period item require evaluation performance otsuka group sustainability promotion committee develop system area sustainability promotion fiscal year establish chair director charge update promotion plan necessary committee overview noncash remuneration restrict stock determine number share allocate grantee restrict stock standard number share set sustainability promotion otsuka holding member comprise group officer charge area relate fiscal year individual give consideration performance duty responsibility weight versus fix remuneration basic remuneration base standard number share share allot series fiscal year time fiscal year evaluation period fiscal year accord committee promote sustainability entire otsuka sustainability supply chain environment human release condition table restrict stock allocation agreement conclude grantee stipulate transfer restriction restrict stock shall remove company shall group act engine discussion decision resource corporate governance compliance risk acquire share pay compensation certain event occur make direction sustainabilityrelate management public relation sustainability composition remuneration director remuneration director subsidiarie activity plan measure committee meeting promotion ir corporate planning department exclude outside director operate company otsuka group hold regularly discuss direction evaluate activity otsuka holding function secretariat remuneration plan emphasize mediumtolongterm remuneration director subsidiary operate enhancement corporate value design performance company determine base duty responsibility apply deliberation link remuneration percentage total remuneration varie include execution business operating company base otsuka holding otsuka group sustainability promotion leader accord company singleyear mediumtolongterm group strategy formulate company formulation board director otsuka holding director consolidated performance strategy operate company strengthen corporate approval rough guide ratio remuneration remuneration governance shall exceed upper limit remuneration type performancelinke bonus design variable resolve shareholder meeting proposal approval promotion range fix remuneration sharebase payment note restrict stockbase range fix remuneration performance compensation system newly implement fiscal group company link bonus sharebase payment combine roughly apply director exclude outside director certain otsuka group sustainability promotion committee secretariat executive charge maximum total remuneration total major subsidiary group examine promote direction strategy field sustainability fiscal year evaluation allotment ratio summary release condition allocation timing promotion promotion promotion condition incumbency subject fiscal year series allocate year take single fiscal single fiscal year standard number share release combined incumbency condition year evaluation period share consolidate revenue operating profit target achievement group company rate share information promote activity field evaluation period fiscal year evaluation period value fiscal fiscal field promotion committee member promote series b fall value achievement th e sh amar ee mor e ah te hh er e ste fs ta hl elo pc ea rt ie od cumulative plan value consolidate share information promote activity seven main group standard number business profit rd expense medium operating company sustainability public relation department mediumterm share evaluation period fiscal year term management plan performance target fiscal fiscal cumulative actual value consolidate share year allocate otsuka otsuka time start period business profit rd expense evaluation period otsuka pharmaceutical taiho otsuka otsuka otsuka medical pharmaceutical pharmaceutical warehouse chemical food evaluation period fiscal year factory device evaluation period value fiscal fiscal series c fall value share year allocate satisfaction time start period cumulative consolidate cost capital standard number calculate accordance consolidated capital cost mediumterm cost share evaluation period fiscal year ratio evaluation period capital condition fiscal fiscal cumulative actual value consolidate share year allocate net operating profit tax evaluation period time start period otsuka holdings co ltd integrate report otsuka holdings co ltd integrate report director audit supervisory board member march director outside director och tsir uo ka ha igts uu co hi mo th si uro mu ak ti u tani k seo kiguchi ao os kh iihisa c r dh e irpa ei r cr e tm oea rnn aa tn ivd e p r dr e ie rp es ri ced ts oe en rn ct en oid v e de irn eio ctr ranage outside director outside director outside director profile profile profile profile profile profile apr join otsuka pharmaceutical factory inc mar join otsuka pharmaceutical co ltd apr join otsuka pharmaceutical co ltd apr intern pediatric department st lukes international hospital apr join mitsubishi corporation apr join itochu corporation jun executive director director consumer product development jun senior manage director otsuka pharmaceutical co ltd jan vice president associate general manager general affairs oct joined ministry health welfare present ministry health join boston consulting group jun executive officer itochu corporation division otsuka pharmaceutical co ltd pharmavite department otsuka pharmaceutical co ltd labour welfare jan general manager sterrad business division johnson johnson apr manage executive officer president food company itochu jun manage director responsible consumer product publicity nov executive deputy president executive director otsuka jun vice president general manager general affairs aug directorgeneral health policy bureau ministry health labour medical k k present johnson johnson k k medical company corporation promotion development division otsuka pharmaceutical co ltd pharmaceutical co ltd department otsuka pharmaceutical co ltd welfare nov president representative director janssen kyowa co ltd apr member board senior manage executive officer dec executive director research development otsuka jun executive director responsible business otsuka nov senior vice president general manager general affairs aug director national sanatorium tama zenshoen present janssen pharmaceutical kk president food company itochu corporation dea cy p r e ph x ea p acr rr um mes ta aie vc cn ee et u ua dtt teii ivc cpea au l l tf fyia r pc ce rt tc eo ot sor riy ydr e ion nnc ct ts au nk da p rh ea pr rm esa ec ne tu att ii vc ea l df ia rc et co tory r onc ts uka j ju un n p p c eh xr oe ea cr um l te ta d vnc ete u dnt ii rdc ea crl e oc p ro r oe tl e st n ud k pv ad rmire ac ct eo ur io cat ls u ck oa p lh tdar maceutical jul e cxe oatp e n r lnr g tt dm il n gn e dlt iw ri eoi ct nh tos r cd osit u rio pkn oaa rp al h tr ee r amp mn cs e ii nub iti sl ti ct ray l f ico n l e olg ta sl u kaff hi ors l da nd g mp e acr r p v ue c tes si ip de r een st di ena ct ti oo rn n oel r ti snn uas kt ti ou n ht ae ol l duf np gvu seb r cl sic ot h oe la f dl ht h e ult rh r ea nn td welfare j ju ac nl c ru eh p pa r ri e erm sea e nn ta aa tn ivvd eis od dri ir r e j eac ct n osr r e j dna k joe awn p aak n c pw r ea l c ed l htd ia japan j mua n ar r od u um ts si ii dn e eis dra ir rt e eiv c ce r r f ofic r tae sutr k co hc rh opu lo c r inao gtir sop n co r oa c u io r lr tn e n c u curr rn ent dec p fare cs ti od yn n cn representative director otsuka pharmaceutical jul p cr oe le tdn cn ud rr er ne tp resentative director ceo otsuka holding mar ldio inr gm cn oa g ln tg director corporate administration otsuka jun president japan public health association current mp ar r ou ut ts si d de e di ir ec ct r n kei nc e c ixo r inp co ration present solasto corporation jul executive director otsuka holdings co ltd dec executive director otsuka chemical co ltd jan executive director otsuka medical devices co ltd current mar outside director otsuka holdings co ltd current jun executive deputy president executive director otsuka feb president representative director otsuka pharmaceutical mar senior manage director otsuka holdings co ltd current holdings co ltd co ltd jun representative director otsuka pharmaceutical factory inc mar chairman representative director otsuka pharmaceutical vice chairman representative director otsuka holdings co ltd current co ltd mar executive director otsuka pharmaceutical co ltd current chairman otsuka pharmaceutical factory inc current chairman representative director otsuka holdings co ltd current outside director audit supervisory board member mu ak ko ino tah ku aic gh ii toa bd eanobu e cx fe ocutive director e b mx u ae nic nu aet gi ev se mp er nir te f oct lio executive director mayo bz ao h suir whi ra mita standing audit outside audit outside director supervisory board supervisory board member member profile profile profile apr join otsuka pharmaceutical co ltd apr join tobishima corporation apr senior manage director representative director shinko apr join baxter limited sep join otsuka pharmaceutical co ltd foods co ltd present otsuka foods co ltd profile profile profile sep pr r j v v po hi ii et c ci r pe e eu c mk p ptd ro tr r e em r ch eet io ds uf nu l e e td ttk n n ih ci n toe g lp c ds csh uo ica r r oke err op c c l ho oa r tlac r r dot e ole du f f f not ai ic h gn e sa cl n occc c uooo e nr p ill tt gr dd c dc eo e f pu n rt ti nn mcg ee nd te p oa c tr c st um u ke ann tt g j muu l ag r f c c p v p ci h hio eon ora e p r rn pl c ct rr ae ea lc c td e eie rdu u ie sefp ni ii oc n ta tr st rl ln uec fc kae e p acn pt n l ro ra vif bc c il tneo ei u f lona imrt d tgi edv dii eo b ppn u ra e r sio n emt e ns teu n ok ta tp ush kt usa akur pm k haa c mu cic ea ul tical j n ju uol l v e f e c p c eox x r xh oee e eo e sc c cd m u u ud lst te tii icc dnv v va e e eo tl ad dh nle e io rdtp p eld cu u r tnt e oy g p r p p r er r oce e tes si nd u e e kaln n v h e n p ld dr e ir nr r es ge e e cp p stn r r ce e r os oe e n n u lst ta u tk dt kai v v ce e c hd hei emr e mic c c co al r r lc ho ot l du u l itk k nda g j dap e en c cr j e q e ei ac nun ns u iie ou ard rb gt iri ies neh dgo vc e r u idg ira rcj ren h cm l tt nd odt va rr ev n g smsl te mony erj ga not h ap nna e b n l ae sl ny tts ah ke nc ic e na lu ec grr yu e bt r ji ue mi ps se ias nc n erco g ss sa e nl u c ul nsd rt ta p e hl sr e ee c e loj tan hpt c la atn rd e j j ap n n ar j c c co h f hpi rn oee eee cm mr atd toi c cr io r na cl g lt n ec h u llo ook e f la r n f c ic l g neath gd rmt ie b n cn h f ooc c r e ml n lh tt e ti rl n poin rstg es ss u e k tc neao tm c h dl tset e ud p k c rp cr mle hhs e ee n mn l tdt ci oo n ag lt ss cuu c okk aoa l tl dt f juec c nbt j j v co ouci hn n e tm se e ip ld da tr et dec u ah e d lu u co l e uo dli not c r ta e u nwtd ts iut l ul c c pch eo ae rr p vp iioo sta ohr la rm ymti ao batn os nu aa r g dp e r mmes e ee n mn tt b c ed l oo li tt st ue k aco uu hrc r oh e ldne n gs apr v c v oi io tc c se e u klp p atr rde e ps si hd ae e rn n mt cei ir r ue e tc c ict alr r co f h h le e dt fa inx nce ep r ce cn ot u tt insu gk da eh po al rd tmin eg ns j man r en e xd eni io u p r ir v viv eica dete ip r el rei cm toidit ree nd fit n ap nre cs ei ae nn dt bs uo sf infi ece ss pot rtu fk oa li oh mold ai nn ag gs e c mo e n tl j ju un n v l cti hdc ae rc mh aa nir ana dn ra en pd r er se ep nr te te ivn et dti iv ree c toir c oto tsr u ko cu hk ea fo ico ad l c c oo l td mar ouit ts su idb eis h di ru ecf tj r tg sa un k ha dey ge sc cur oit ie ls dc c u l rt rd e not j du en c c exo e epr cp uo r ttr m va et ee dn irf ef cic tte osur r k cai rpoct oldo rir g ef ct mc nlr tp isdo rr aa tt ie nf aa cn cc oe u n ta inc gc au nn dt tg j ou cn p ohu uat trs smi d dae ec deuu irt ed ccit ta l rc nu ip p e l ptr odv ni pr ay r kb io na gr em vee lm opb mer e tt cu ok ltd ar r e ex xe ec cu ut ti iv e di ir ec ct r c co forp ora tst ue kf han oc lde n gst cu oka h lto dl cug rs r ec ltd e hx ot es lu c duk inta gv p se h cda irm e ltc de r u b cic u ua rl r n ec e pl otd rt f oc lu ior r man n gement otsuka j ju un n v cti oac e n lc tnh dga ir ua dn ss uu pk ea r vf io od rys bc oo r dl md ember otsuka holdings mar e cx ot es ru c puk ota riv ac e te h v e sim c ee ri v c p ia crl ee c dio e e p n al tt rd c er np r oat te su f kin hn oc le n ga sc cco ou n lt tin dg mar ltu dd c u r rs eu np te rvisory board member otsuka pharmaceutical co nov president representative director otsuka foods co ltd mar stand audit supervisory board member otsuka holdings jun executive director otsuka holdings co ltd current co ltd current mar chairman otsuka foods co ltd mar cu ud rri et n supervisory board member otsuka chemical co ltd mar executive director otsuka foods co ltd current yoko kazuo masayuki noriko makoto wachi takahashi kobayashi tojo inoue outside audit outside audit executive director executive director executive director supervisory board supervisory board member member profile profile profile profile profile apr join daiwa bank ltd present resona bank limited apr join goldman sachs japan corporation apr join otsuka pharmaceutical co ltd apr register attorney law daiichi tokyo bar association apr join ebaraudylite co ltd present jcu corporation oct join taiho pharmaceutical co ltd aug join shearson lehman brothers holdings inc jun vice president general manager diagnostic division otsuka join kajitani law office current mar executive director strategic planning ra institute co ltd aug president taiho pharma usa inc present taiho oncology inc jul engagement manager mckinsey company japan office pharmaceutical co ltd jun corporate auditor nichia corporation nov executive director general manager system division ae p p pp r r r e p p l e ctx r r x hde ee e c c iu ud rc mt te e ui nv v ert ne dn n n tti ir r ad de e hc cc rt oeo oe po r r net aso cei oh ht n lso otu gkp pt yah hi v ae ia nr r mm md ci ea ar erc cuie c uc tu sa ro rat e ri ic nn tc nal cic h p l ht ad r maceutical co j f au eu p un bg r g c e p ex r xi er e ee sn c cc u uda lt tgo et d nv vir n e et gi n ad nd ie r rdi e el r e c cc ct tca oetp r r nocl toj u sa cr ukp p ekaa oa n r pei e mn hd aeie c rrl e micc v l ae ado l v r e ip n tvp eo cm c r lea e lst n c co tn ls tu dk holdings j mu pn arr r b e n e pxe x hu u ae en nc ci ri rno u u maer ct g ai ev v v cnue e egc ud de ci tv ip r iri cile e rr ai ee c c b lt cs n oi cu td r rs e ro n en p nx e hs l e au u tscd drk u md atp cvvpu v eieh st u tay v e r inig cc l aee l l cn spc te e r bser u u ua st k sil c iam nea epnla shtcn g rg om ee tal nr st c ueo er kf u lp imh caa lr nm oa g c e e r lu tot di fc al jua nr c oo uu tt ss ii l dd ee da iu c ru ed crit r te n r nu ip che ir av sis cor oy r pb oo ra ar td io n e cm urb er n tsuka holdings mc e k e c exu x x u ee e en su cc c nk uu un vu tt ik rs ii vov vu e ee e ns r dca ii io es rr r es fe e crc c tc l ono oi la rcr r h e hh c ais e ne h e aai ai en de g fc r oe e ff f l et th rh ni eoe e sn f f rf oa f ao ncfr f em cic hg e c ie st e io ra c e nn cln ed r ky cs hs l et st ere u km nnt e skt g ue ury ni sv n koi cas ui lf f c cc e l nc dt ti rhr loc te e mar executive director otsuka holdings co ltd current jan president representative director otsuka medical device sep executive director daiya foods inc executive director head information system division circle k co ltd current mar senior manage director nutraceutical business otsuka sunkus co ltd executive director otsuka america inc pharmaceutical co ltd mar outside audit supervisory board member otsuka holdings aug chairman pharmavite llc oct chairman nardobel sas co ltd current mar executive director otsuka holdings co ltd current mar executive deputy president executive director otsuka pharmaceutical co ltd mar president representative director otsuka pharmaceutical co ltd current executive director otsuka holdings co ltd current otsuka holdings co ltd integrate report otsuka holdings co ltd integrate report discussion corporate governance outside director inside director discuss corporate governance otsuka holding corporate governance system effective corporate governance otsuka balance fact female director holding inside director significant hand grow importance overseas operation company aoki proactive promote human resource otsuka holding current structure company familiar overseas business conduct variety board director execute business audit business people share longterm supervisory board feel structure work vision group ascertain change condition result environment audit supervisory status business detail easy feel board member outside director exchange candid important company create system set opinion reserve think opinion kpi business track business target respected decision make thing stand help level achievement reliable oversight believe maintain effectiveness corporate governance business monitor management practical term society increasingly call great effective separation supervision execution closely monitor trend work improve system sekiguchi think cultivate management personnel consider significance corporate governance important factor properly maintain governance purpose mission hold company think addition training management skill think otsuka otsuka holding ask raise conduct training place emphasis collective strength otsuka group high level management morality word cultivate sense perspective think fully discuss ethic maintain sound management examine optimal structure otsuka group sale yukio matsutani ko sekiguchi composition aim go forward outside director outside director mita business environment change tremendous speed member corporate governance committee member corporate governance committee female director provide adequate gender bring factor include covid pandemic yoshihisa aoki mayo mita yoshiro matsuo shuichi takagi outside director outside director senior manage director executive director member corporate governance committee member corporate governance committee charge otsuka group sustainability promotion business portfolio management head otsuka group global environmental council member risk management committee member corporate governance committee otsuka holdings co ltd integrate report otsuka holdings co ltd integrate report expertise line enable expeditious discussion mita board meeting hand think consider high degree transparency receive reference current system acceptable stand material remuneration system comparison function different order adopt company information facilitate lively company future exchange opinion deliberation hand impression slight lack speed matsuo incorporate opinion outside director structure year company stock list system business topic diversity inclusion group collective strength corporate governance system important society impression appropriate list company enhance woman active taking lead actual business firm footing issue remain execution otsuka coincidence woman otsuka consider truly global company able play active role support ongoing animate discussion director special mechanism promote woman high ideal form corporate governance receive position improve motivation role share woman insightful opinion outside director mutual support system like discuss point diverse background stage otsuka group strengthen corporate function matsuo adoption digital technology keep difficult achieve result increase corporate value corporate governance committee comprise audit supervisory board member corporate way succeed go forward maximize group synergy amid dizzy outside director president director charge governance role committee change accord increasingly important establish forum suggest change operate environment company administration organize hold widerange discussion business social environment believe role discuss otsuka prioritize take action grow simply play catchup necessary accelerate nomination remuneration director otsuka holding evolve forum bring everyone ability act evolution look ahead medium long term stage people openly talk demonstrate key function otsuka holding lead entire group collective strength group stay ahead understand importance cultivate human global governance operating company time bring otsukas advantage fore resource management open company external human resource aim maximize corporate takagi value premise accept society otsuka group conduct management operating company respective operating board director company operate social impact believe generation management respect diversity originality operating company new form mechanism system executive director multiple director establish system enable otsuka compete company promote global expansion trust verify creation mechanism serve concurrently management team operate global level global company achieve mediumtolongterm growth weather group expansion help maintain company bring critical external perspective thought issue management face sustainably governance enable sound group development maintain unified consistent overall direction end think cultivation diversification management manage diversified business personnel essential corporate governance committee matsutani sekiguchi otsuka start expand overseas early stage decentralize management require unify force company establish corporate governance solidify business foundation long fall apart centrifugal force strong committee advisory body board director history governance develop business think otsuka reach stage strengthen deliberate nomination director audit environment completely different region governance word control global business supervisory board member remuneration system country think governance difficult coordinate support department establish otsuka holding standard director corporate governance fortunately effort line business feel make progress strengthen global matter describe status effectiveness stayed align otsukas philosophy governance risk management important global committee necessary strengthen mechanism governance like function enhance achieve go forward matsutani think committee effective problem aoki takagi current system stage believe process sense global governance otsukas operating management operating company allow appropriate ensure transparency objectivity company drive excellent management skill certain degree freedom encourage independence hand overseas business account half leadership successive management team creation innovative idea previously point sale real term system sufficient group grow current scale feel otsuka proactively promote globalization control overseas operation grow extent need reconfigure system otsuka holding early stage start restriction foreign otsuka holdings co ltd integrate report otsuka holdings co ltd integrate report central nervous system iv solution business make opportunity shift digital realm progress cooperation otsuka pharmaceutical crucial question otsuka well use otsuka pharmaceutical factory aware shift develop product service stage step group governance use digital technology improve efficiency sustainable growth otsuka group strengthen area promotion new product development monitoring function building system collaboration capture need new era operating company matsuo matsuo digital technology strategy passive matter business expand diversify view ahead company otsuka continue uphold approach business proceed stage set forth digital system unwavere actualization creativity technology strategy core strategy pass successive management team organization mediumterm management plan sustainability reproducibility important group future recognize intrinsic aspect business activity stick successful past view lead otsuka signatory united build structure reproduce vision nations global compact people rally organization otsuka appeal company fulfill investment circumstance difficult import believe structure board director worldwide pocari sweat calorie mate corporate responsibility sustainable society japanbase management globalization progress need evolve change line otsuka group think great demand product longterm perspective country recent year otsukas governance stage direction perspective management preventive approach maintain health future earning base intend invest mediumto system evolve groupwide assetshare supervision maximization group synergies global like otsuka focus create product longterm growth stay commit maintain way therapeutic area oncology governance nutraceutical business current business performance otsuka capable identify overcome issue look mita future idea unlike company otsukas social role new normal achieving amid grow social trend health awareness continue strive vibrant active company believe otsuka group widerange portfolio opinion differ diverse type business sustainable society longterm product brand development core diverse management personnel alternative strength company unique opinion position able provide comprehensive healthcare senseles lively exchange opinion worldwide covid pandemic major change accordingly solution company strategy align like lie groundwork stage create impact society people lifestyle great change increase use sustainable approach keep product business organization reproducibility thought opportunitie risk new normal information technology advance go indefinitely surely difficult era rapid go forward otsukas role future issue think large impact rapid uptake change otsuka focus short term unique total healthcare company elderly child affect entire medium term long term make decisive addition recent year increase corporate supply chain make essential company investment view future necessary call contribution sustainability great prepare situation company sort long demand demand corporate social responsibility deal visible primary impact change time mean otsuka holding otsuka aim achieve sustainable growth contribute need develop flexible system respond secondary shortterm orientation vision healthy sustainable society base tertiary impact strategy look ahead corporate philosophy business activity help resolve social issue thought aoki sekiguchi direction otsuka issue go find phrase unique total healthcare company otsuka scope business total healthcare company forward appeal think people want lead healthy long extremely important new era enjoyable beautiful live otsuka operating concept prevention presymptomatic healthcare matsutani line perspective think continue measure individual health management apply covid pandemic substantial impact direction achieve sustainability otsukas control infectious disease company end sight strength solid business structure profit addition wake covid pandemic pandemic subside individual lifestyle social condition pharmaceutical business culture tenaciously considerable business operation completely different company require engage creation product benefit people otsuka holdings co ltd integrate report otsuka holdings co ltd integrate report compliance tax compliance establish otsuka group global code business ethic openly convey information stance otsuka group comply otsuka group global code business ethic group tax policy countryspecific law relate initiative website form message president otsuka holding furthermore regulation tax treaty international taxation rule engage transaction design evade formulate otsuka group global anticorruption policy express stance corruption site worldwide payment taxis carry appropriate filing payment taxis country endeavor appropriately otsuka group global policy conflict interest aim maintain objectivity business otsuka group global disclose information ensure degree transparency trust deal tax authority country privacy policy define stance guide principle privacy protection policy form basis conduct complexity tax oversight increase business global continuously update information engage business high ethical standard prior consultation tax expert necessary appropriately respond order minimize tax risk compliance promotion system correspondence tax authority submission relevant authority necessary otsuka group global anticorruption instill compliance group company otsuka group otsuka group engage constructive relationship tax use advance pricing agreement apa obtain ahead policy conduct universal training base content authority countriesregion operate oftime consensus tax authority otsuka group global anticorruption policy embody policy training material distribute operating company continue improve reliability tax datum establish reiterate steadfast commitment conduct officer employee contract employee dispatch system provide promptly governance employee operate company attend related training business integrity compliance relevant work maintain improve taxrelated governance anticorruption law policy outline prevent annually submit sign declaration observe transfer pricing policy recognize contribute enhancement regulation level understand compliance detect deter violation anticorruption law set otsuka group calculate transfer price base oecd corporate value end active involvement penetration employee evaluate test forth global minimum standard guideline create prevention double cfo strengthen cooperation department train awareness survey measure result prevention corruption apply worldwide training status submission declaration form taxation fair application transfer price tax system operate company secure training business operation regularly report meeting board director country transfer price tax system make capable human resource maintain appropriate httpswwwotsukacomencsr operate company establish related regulation effort ensure proper transaction relate party system enhance tax compliance reduce tax risk governancepdfotsukagroupglobalanti accordance law country conduct legal recent year oecd issue action plan base erosion furthermore establish reporting obligation corruptionpolicyirpdf compliance addition operational status internal profit shift bep multinational corporation board director audit supervisory committee reporting system internal audits major group company engage international transaction lead double non abovementione policy process regularly report meeting board director otsuka otsuka group global policy conflict taxation properly execute obligation ongoing implementation maintenance holding interest otsuka group recognize conflict interest monitoring group individual employee matter hold company role maximize otsuka impact integrity organization group corporate value otsuka holding establish system risk management great bear group future base thinking ensure appropriate business operation perspective formulate otsuka group global policy conflict group establish system facilitate interest prevent conflict work cooperation otsuka group system affiliate otsuka group carry risk management supervision management base recognition pursue company report otsuka holding necessary item management efficiency control risk inherent business activity important enhance corporate value instill policy global level specify affiliate company management regulation httpswwwotsukacomencsr obtain approval relevant important item governancepdfotsukagroupglobalpolicyfo example overseas initiative include appointment rconflictofinterestirpdf compliance officer group company asia risk management system detail risk management activity hold regular meeting share status progress enhance risk management otsuka holding conduct risk assessment risk awareness management otsuka group global privacy policy country director charge compliance visit main operating company company introduce enterprise share management interview otsuka holding recent year country enact privacy company gather information offer suggestion risk management erm july purpose main operating company topdown approach improvement protection legislation european union general recognize assess groupwide risk prioritize assessment risk control conduct frontline addition internal audit department direct datum protection regulation gdpr implement allocation resource control principal risk employee bottomup approach enable authority president establish conduct regular otsuka group working strengthen privacy erm activity establish groupwide comprehensively identify risk exist group audits base internal audit rule verify operation protection addition formulate otsuka group risk management framework system risk assessment company formulate risk management policy risk execute appropriately efficiently regard global privacy policy define stance guide asset business general otsuka holding affiliate identify principal risk risk assessment management action plan risk judge principle privacy protection establish relate rule company department submit audit report main operating company formulate countermeasure principal risk regularly review risk situation review management system accordance president director audit supervisory board member risk progress action plan law regulation relate privacy protection case find need improvement department risk management activity report risk addition otsuka holding aggregate visualize country issue improvement advisory follow check management committee chair president result group company assessment gain httpswwwotsukacomencsr implementation status measure ascertain execution representative director company risk management comprehensive understanding risk exist duty suitably improve addition department governancepdf committee monitor principal risk examine past risk control situation group base result otsuka otsukagroupglobalprivacypolicyirpdf share information audit supervisory board member management activity consider proposal holding identify group principal risk accounting auditor coordinate unify stance improvement regularly review risk management system otsuka holdings co ltd integrate report otsuka holdings co ltd integrate report risk management system item response risk management committee decisionmake board director chair president representative director risk relate uncertainty review research development direction appropriate new drug development enhance pipeline decision status risk management implementation monitor risk reduction measure report status monitor status risk management form appropriate strategic alliance make acquisition risk management review risk management system risk relate business alliance detail diligence valuation target company asset extensive discussion board director business risk relate acquisition operation monitor investment visualization company risk management business strategy develop inhouse talent pdca initiative group risk adopt stateoftheart technology conduct proofof identification risk relate digitalization concept demonstration practical application otsuka holding group principal risk hold seminar improve literacy provide product appropriate price demonstrate risk relate healthcare cost value new drug containment measure contribute control soar healthcare cost total healthcare company establish global safety management structure risk relate effect centralize management safety information establish system implement safety measure plan check action compliance legal regulatory requirement governmental industry standard awareness review risk risk relate food safety acquisition certification specification monitor management risk otsuka holding risk formulation management management status indicator main operating identification risk activity monitor evaluation encourage acquisition international standard certification company rif kh si g ah e es c h poa ln ica ieg se ne dn b ne ad g en r eis nk io nf r ii cs ak om ra snagement formulating business continuity plan awareness company action plan policy review report conduct regular drill action plan progress action risk relate natural disaster conduct simulated desktop simulation drill jointly workplace risk reassessment group company pandemic risk promotion measure covid establishing enhance workfromhome system web conferencing system risk relate fair equitable transparent procurement build good relationship supplier production risk relate supply chain ensure stable procurement supply raw material principal risk marketing product disruption conduct risk assessment groupwide risk assessment otsuka group recognize business risk establish system ensure business continuity event follow principal risk otsuka holding key operating httpswwwotsukacomenirmanagementriskhtml covid pandemic company take step mitigate purchase raw material multiple company gather information market trend secure risk relate raw material price alternative raw material item response increase maintain appropriate inventory reduce cost improve productivity establish otsuka global academy talent recruitment declare diversity promotion otsuka group global code focus research development new product risk relate development risk risk relate expiration business ethic provide relevant system mechanism drive sustainable growth management base patent protection initiative extend lifecycle product determine materiality resolve social issue business corporate philosophy risk relate corporate social activity responsibility risk relate patent establish management system intellectual property right establish otsuka group sustainability promotion committee infringement conduct investigation gather information strategic allocation managerial resource measure establish internal reporting system business risk relate litigation cooperation outside counsel etc establish otsuka group global code business ethic risk hold company relate global policy establish otsuka group global information security policy risk relate upgrade internal monitoring framework establish risk relate information education training executive employee groupwide internal reporting system management business strategy establish group information security committee ensure financial soundness risk relate risk relate corporate brand establish ci management committee business management r oi ps ek r r ae tl ia ot ne sd global business bap sp er p ni tt e loa cn aa l g oe pm ere tt gn ed n vu ip rop mrt e f tr business operation inhouse training management reputation formulate otsuka group pr guideline risk relate foreign exchange use forward exchange contract stock price diversify periodic review portfolio otsuka holdings co ltd integrate report otsuka holdings co ltd integrate report esg content index detail sustainability initiative visit httpswwwotsukacomencsr addition information include integrate report otsuka group disclose follow esgrelated information website visit website detail item policy commitment system initiative item policy commitment system initiative overall signatory united nations global compact sale basic policy page conduct appropriate marketing promotion activity compliance law sustainability mission marketing establish internal code practice expand regulation materiality page jpma promotion code prescription drug activity gather disseminate information product relate knowledge late goal progress page target healthcare professional academic information etc stakeholder engagement structural measure establish scientific employee training sustainability management structure page affairs department gathering disseminate reduce food loss extend shelf life switch monthbase expiration date external recognition information product relate knowledge etc datapeople environment governance late academic information dedicated review unit ensure appropriate marketing promotion activity society health basic policy customer service basic policy page promote customercentric management pharmaceutical basic policy contribution unmet medical need page declaration customercentric commitment ensure appropriate communication customer business goal progress page initiative access medicine improve product base customer feedback fy goal quantification fy progress initiative infectious disease include tuberculosis groupwide customer service liaison meeting cross establish dedicated contact point patient healthcare professional department listen customer feedback meeting customer respectively nutraceutical basic policy catering yettobeimagine need promotion structure consumercentric business goal progress page initiative access nutrition page management environment environmental otsuka group global code business ethic environmental protection people basic policy management otsuka group environmental policy otsuka group environmental activity guideline human resource basic policy human resource development program include management human resource group promotional structure center otsuka group global environmental council development development program disclosure iso certification status internship program system leverage ability open recruiting system selfassessment system etc climate change basic policy initiative efficient energy use co reduction expand use renewable goal progress page energy source introduction cofree electricity include solar power diversity otsuka group global code business ethic diversity diversity generation inhouse consumption purchase green power certificates inclusion inclusion system diversity promotion include mindset establish structure help etc page basic policy diverse human resource play active role regardless nationality race age gender validation goal science base target sbt initiative signatory women empowerment principle wep disability sexual orientation etc disclosure co emission datum iku boss manager supportive worklife balance example external recognition declaration group company resource basic policy initiative achieve zero waste recycling goal progress page initiative plastic resource marine plastic pollution health otsuka group global code business ethic initiative employee health maintenance promotion disclosure waste volume effective use volume final disposal volume safety human right labor standard employee initiative workplace health safety conservation datum health initiative reduction overtime encourage employee pay leave basic policy example external recognition water basic policy water risk evaluation manufacturing site page declaration health group company conservation goal progress page disclosure water usage water use efficiency datum health safety committee promotion structure governance corporate basic policy fair employment otsuka group global code business ethic internal training bully harassment issue governance corporate governance guideline work h ah ru asm sman e nr tig h n dn r l ea pb oo rr not ga n cd oa nr cd es r n iscrimination employee survey improvement activity base survey result governance basic policy disclosure corporate governance report condition basic policy structure overview governance structure initiative strengthen corporate governance board director audit supervisory board corporate governance committee human right otsuka group global code business ethic implement human right risk assessment identify salient human right risk initiative h ah ru asm sman e nr tig h n dn r l ea pb oo rr not ga n cd oa nr cd es r n iscrimination wde hn ist tif ley bin log w sa inli ge n ht h tlu inm ean right issue implement corrective measure sr ka li lo mna al te ri xfo fr r e dle irc et cio ton r f nd dir e ac uto dr sd u e pv ea rvlu isa oti ro yn b rb mar ed e bff ee rc st ve pn ae gs es page basic policy employee train otsuka group human right policy succession plan otsuka group human right policy external collaboration promotional structure remuneration basic policy disclosure corporate governance report director remuneration standard system method determination quality basic policy audit otsuka group global code business ethic business integrity maintain book record etc supervisory certification status iso quality iso fssc food safety etc board member research commitment rd compliance law ethical consideration research involve animal development guideline ethical consideration etc page ethical consideration research involve humanderive specimen compliance overall basic policy ethical consideration research involve pathogenic microorganism pathogen compliance promotion structure genetically modify organism ethic clinical trial tax compliance basic policy correspondence tax authority compliance rd otsuka group company tax policy management public research fund transfer pricing policy procurement basic policy page promotion sustainable procurement consideration environment anticorruption otsuka group global code business ethic bribery diligence otsuka group procurement policy human right matter corruption etc train employee otsuka group sustainable procurement guideline include diligence investigation new supplier common saq otsuka group global anticorruption policy monitor sustainable procurement promotional structure briefing session business collaborator page establishment otsuka sustainable procurement task joint business collaborator audit pharmaceutical company conflict otsuka group global code business ethic conflict train employee force page global initiative streamline production supply product interest interest etc monitor goal progress page otsuka group global policy conflict interest production basic policy page production quality control patientcustomer safety compliance protect otsuka group global code business ethic privacy training employee quality control measure include global product quality policy regulatory requirement governmental industry standard privacy confidentiality etc monitor pharmaceutical product otsuka pharmaceutical acquisition iso quality iso fssc food safety etc otsuka group global privacy policy patient promotion structure include global production meeting quality control base gqp gvp postmarkete safety management customer safety global product quality meeting global implementation pharmacovigilance activity whistleblowe provision internal external whistleblowing hotline measure falsify medicine hotline employee training risk overall basic policy identify principal risk risk assessment mitigate risk page logistic eb sa ts aic b lp iso hl micy e not p oa fg te hs e g p promotion office win ii tt hia ti hv ee g f oo dq u da il si tt ry bc uo tn iotr l p ran cd m cea gt den pa n gc ue d ep lr ino em ei mon p lo l eo eg tis rt ai ic ns nin g c eo tm cp liance management r eni tk e rm pra sea g rie sm k man n p ao gl eic ent b ru iss ki n ass n aco gn emtin eu ni tt rp al ia nn inn ging management promotion structure control maintenance initiative streamline cooperation shipper distributor risk management system operate risk initiative mitigate information security risk product quality stable supply logistic standardization itbase data system digitization form etc management committee initiative stable supply distribution strage inventory registration vehicle authorize access restrict area etc contribution communitie policy activity contribute community environmentally friendly measure promotion modal shift reduce co emission otsuka holdings co ltd integrate report otsuka holdings co ltd integrate report financial nonfinancial highlight visit otsuka holding website key sustainability data httpswwwotsukacomencsrdatapdfmajorcsrdataenpdf revenue overseas revenue ratio business profit business profit margin ratio revenue number employee number female manager female manager ratio revenue overseas revenue ratio business profit business profit margin number employee number female manager female manager ratio billion billion plan plan revenue leave overseas revenue ratio right business profit leave business profit margin right outside japan japan number female manager leave female manager ratio right scope production site consolidate otsuka group scope fiscal company otsuka pharmaceutical otsuka pharmaceutical factory taiho pharmaceutical otsuka warehouse otsuka chemical otsuka food fiscal company company plus otsuka pharmaceutical development commercialization otsuka america pharmaceutical pharmavite fiscal company company plus otsuka holding otsuka medical device profit attributable owner company return pharmaceutical business equity attributable owner company roe rd expense rd ratio ratio revenue number employee take parental leave co emission co emission sale profit attributable owner company return equity attributable owner company roe rd expense pharmaceutical business employee take parental leave total co emission billion billion thousand tonsco ton million japan indonesia india north america south korea china europe plan plan profit attributable owner company leave rd expense leave female male total co emission leave co emission sale right return equity attributable owner company roe right rd ratio right scope fiscal company otsuka pharmaceutical otsuka pharmaceutical factory taiho scope production site consolidate otsuka group exclude impairment loss pharmaceutical otsuka warehouse otsuka chemical otsuka food fiscal company company plus otsuka pharmaceutical development commercialization otsuka america pharmaceutical pharmavite fiscal company company plus otsuka holding otsuka medical device total asset ratio equity attributable simple incineration landfill volume owner company total asset annual dividend share dividend payout ratio water usage water use efficiency total waste volume total asset annual dividend share water usage water use efficiency total waste volume billion thousand million ton ton japan southeast asia east asia south asia north africa north america south america europe plan total asset leave annual dividend share leave water usage leave water use efficiency right simple incineration landfill leave total waste volume right ratio equity attributable owner company total asset right dividend payout ratio right scope production site consolidate otsuka group scope production site consolidate otsuka group otsuka holdings co ltd integrate report otsuka holdings co ltd integrate report main datum effect fiscal end december otsuka adopt international financial reporting standard ifrsinformation fiscal end december present line ifrs jgaap ifrs ifrs item unit unit result operation revenue billion million sell general administrative billion million expense business profit rd expense billion million ratio business profit rd expense revenue rd expense billion million rd ratio business profit billion million business profit margin operate profit billion million operate profit margin profit attributable owner company billion million financial position total asset billion million total equity billion million ratio equity attributable owner company total asset roe cash flow net cash flow operating activity billion million net cash flow invest billion million activity free cash flow billion million dividend annual dividend share yen dividend payout ratio common stock stock price thousand thousand number share outstanding yearend share share stock price yearend yen number employee total person person japan person person outside japan person person line item base ifrs sga expense jgaap present total expense rd expense company believe information useful investor compare company financial result jgaap ifrs exclude impairment loss business profit revenue cost sale sell general administrative expense share profit associate rd expense change consolidated fiscal year fiscal end december transitional period cover month april december december company finalize provisional accounting treatment business combination reflect presentation figure year end december calculate number employee include otsuka holding co ltd subsidiarie otsuka holdings co ltd integrate report otsuka holdings co ltd integrate report corporate information global network group structure overview main operating company corporate profile company organization december april otsuka group corporate philosophy company otsuka holdings co ltd establish july capital billion overview otsuka group company origin date aim contribute health people world aim main pillar pharmaceutical business diagnosis treatment disease nutraceutical business head office kandatsukasamachi chiyodaku tokyo support maintenance promotion everyday health japan companys culture summarize word ryukangodo sweat recognize way jissho actualization sozosei creativity foster successive otsuka leader emphasize employee group company country region strive create market unique product service tokyo shinagawa grand central tower konan headquarters minatoku tokyo japan nutraceutical nutritionpharmaceutical end december otsuka holding subsidiary affiliate telephone organizational structure otsuka holding number consolidate employee otsuka pharmaceutical otsuka pharmaceutical taiho pharmaceutical otsuka warehouse otsuka chemical otsuka food otsuka medical factory device business control management relate activity description respect company subsidiary affiliate operate pharmaceutical nutraceutical consumer product business europe company north japan america otsuka operate asia company middle east company countriesregion south company central america oceania company company gniteem sredloherah srotcerid fo draob namriahc tnediserp internal control department internal audit department nutraceutical business global strategy planning headquarters corporate planning department global business support department finance accounting department project office tax department corporate service department business development department investor relations department administration department president office public relations department sustainability promotion department human resources department human resource planning department planning department legal affairs department statutory auditor board statutory statutory auditor office auditor otsuka pharmaceutical total healthcare company support wellbee body co ltd treatment disease promotion everyday health corporate philosophy otsukapeople create new product well health worldwide otsuka pharmaceutical operate core business pharmaceutical business support diagnosis treatment disease nutraceutical business help people maintain improve daytoday health global network otsuka pharmaceutical original company otsuka group leader iv solution december factory inc japan year experience field base management vision good partner clinical nutrition otsuka pharmaceutical factory create innovative product meet variety need include pharmaceutical medical device oral rehydration solution medical food otc pharmaceutical company operate globally focus japan rest asia taiho pharmaceutical pioneer oral anticancer agent japan half century co ltd taiho pharmaceutical rddriven specialty pharma focus field oncology allergy immunology urology corporate philosophy strive improve human health contribute society enrich smile oncology field particular taiho pharmaceutical know lead company japan actively promote globalization consumer healthcare business taiho pharmaceutical strive research develop novel unique product continue identify people real need meet precisely otsuka warehouse contribute people health worldwide field logistics co ltd found otsuka warehouse develop business emphasis pharmaceutical food product logistic include construct common distribution platform otsuka group core category pharmaceutical food beverage daily necessity recent year otsuka warehouse work extend logistic solution outside group otsuka chemical otsuka chemical creatively give shape power material customer co ltd material core operation otsuka chemical aim continuous technological innovation lead creation product enable high standard live otsuka chemical provide product global market automotive electrical electronic equipment housing healthcare area main segment hydrazine business advanced polymer material business inorganic composite material business pharmaceutical intermediate active pharmaceutical ingredient api business otsuka food co ltd create highvalueadde product offer new dietary lifestyle otsuka food motto company begin people food begin spirit mind employee bring spirit food focus deliciousness safety peace mind well health business today social landscape change dramatically super age society health environmental population issue issue leverage brand otsuka food continue pursue solution address kind social change create provide product customer need seek contribute people world otsuka medical device develop innovative treatment method create new value co ltd establishment february otsuka medical devices co ltd focus develop unique solution improve health patient medical need condition fulfil exist treatment method achieve aspiration pioneer medical device industry combine global rd effort technology drug discovery knowhow inherent otsuka group heritage otsuka holdings co ltd integrate report otsuka holdings co ltd integrate report disclosure otsuka group stock information december otsuka group provide overview financial nonfinancial information number share authorize share principal shareholder integrate report visit otsuka holding website additional information include consolidated number share issue share number shareholde financial statement financial result presentation supplementary document information number shareholder shareholder share hold ratio thousand research development nomura trust banking co ltd otsuka founders shareholde fund trust account master trust bank japan ltd trust account website investor relation httpswwwotsukacoman httpswwwotsukacomenir stock distribution custody bank japan ltd trust account treasury share security otsuka estate co ltd company otsuka group employee shareholding fund company awa bank ltd financial institutions jp morgan chase bank otsuka asset co ltd jpmorgan securities japan co ltd custody bank japan ltd trust account individual foreign note number share hold rounded near thousand corporation company hold share treasury share otsuka group sustainability exclude list shareholding ratio calculate treasury share deduct httpswwwotsukacomencsr japan trustee services bank ltd merged trust custody services bank ltd jtc holdings ltd july change trade custody bank japan ltd maximumminimum stock price volatility year total shareholder return maximum minimum volatility fiscal fiscal stock price stock price standard deviation otsuka holding comparison topix total return index integrate report precaution forwardlooke statement begin fiscal edition otsuka holding combine integrate report summarize operate financial result annual report csr report single integrate report bring otsuka group otsuka holdings co ltd subsidiary fiscal financial information nonfinancial information hope january december report contain deepen stakeholder understand group aim forwardlooke statement forecast pertaining plan projection indispensable contributor people health worldwide strategy performance otsuka group company statement base current analysis belief light reporting period information available issue date report actual result stock performance fiscal january december differ risk uncertainty affect otsuka note certain information january onward include group operation stock price leave trading volume right thousand share scope report medical information principle report cover otsuka holdings co ltd integrate report sake readability unify brand subsidiary scope activity datum narrow detail product different brand name different country note region product available country available different brand name different indication guideline reference different dosage strength international integrate reporting framework international integrate note information pharmaceutical product report council iirc include product development intend advertising gri sustainability reporting standard global promotional purpose medical advice reporting initiative gri iso environmental reporting guideline ministry environment guidance collaborative value creation ministry economy trade industry guideline otsuka holdings co ltd integrate report otsuka holdings co ltd integrate report integrate report year end december responsible management forest resource report print paper produce fsccertified source accordance standard forest stewardship council international certification body dedicate promote responsible forest stewardship control source nonvoc ink free mineral oil